MEPS HC-231 2021 Medical Conditions

August 2023

Agency for Healthcare Research and Quality
Center for Financing, Access, and Cost Trends
5600 Fishers Lane
Rockville, MD 20857
(301) 427-1406

Table of Contents

A. Data Use Agreement
B. Background
1.0 Household Component
2.0 Medical Provider Component
3.0 Survey Management and Data Collection
C. Technical and Programming Information
1.0 General Information
2.0 Data File Information
2.1 Codebook Structure
2.2 Reserved Codes
2.3 Codebook Format
2.4 Variable Naming
2.5 File Contents
2.5.1 Identifier Variables (DUID-CONDRN)
2.5.2 Medical Condition Variables (AGEDIAG-ICD10CDX)
2.5.3 Utilization Variables (OBCOND - RXCOND)
3.0 Survey Sample Information
3.1 Discussion of Pandemic Effects on Quality of 2021 MEPS Data
3.1.1 Summary
3.1.2 Overview
3.1.3 Data Quality Issues for MEPS in 2021 Directly Associated with Data Quality Concerns for the NHIS and CPS
3.1.4 Modifications to the MEPS HC 2021 Sample Design
3.1.5 Data Quality Issues for MEPS FY 2021
3.1.6 Discussion and Guidance
3.2 Sample Weight (PERWT21F)
3.3 Details on Person Weight Construction
3.3.1 MEPS Panel 23 Weight Development Process
3.3.2 MEPS Panel 24 Weight Development Process
3.3.3 MEPS Panel 25 Weight Development Process
3.3.4 MEPS Panel 26 Weight Development Process
3.3.5 The Final Weight for 2021
3.4 Coverage
3.5 Using MEPS Data for Trend Analysis
4.0 National Health Interview Survey (NHIS)
5.0 Longitudinal Analysis
References
D. Variable-Source Crosswalk
Appendix 1: ICD10CDX and CCSR Condition Code Frequencies

A. Data Use Agreement

Individual identifiers have been removed from the micro-data contained in these files. Nevertheless, under sections 308 (d) and 903 (c) of the Public Health Service Act (42 U.S.C. 242m and 42 U.S.C. 299 a-1), data collected by the Agency for Healthcare Research and Quality (AHRQ) and/or the National Center for Health Statistics (NCHS) may not be used for any purpose other than for the purpose for which they were supplied; any effort to determine the identity of any reported cases is prohibited by law.

Therefore in accordance with the above referenced Federal Statute, it is understood that:

  1. No one is to use the data in this data set in any way except for statistical reporting and analysis; and

  2. If the identity of any person or establishment should be discovered inadvertently, then (a) no use will be made of this knowledge, (b) the Director Office of Management AHRQ will be advised of this incident, (c) the information that would identify any individual or establishment will be safeguarded or destroyed, as requested by AHRQ, and (d) no one else will be informed of the discovered identity; and

  3. No one will attempt to link this data set with individually identifiable records from any data sets other than the Medical Expenditure Panel Survey or the National Health Interview Survey. Furthermore, linkage of the Medical Expenditure Panel Survey and the National Health Interview Survey may not occur outside the AHRQ Data Center, NCHS Research Data Center (RDC) or the U.S. Census RDC network.

By using these data you signify your agreement to comply with the above stated statutorily based requirements with the knowledge that deliberately making a false statement in any matter within the jurisdiction of any department or agency of the Federal Government violates Title 18 part 1 Chapter 47 Section 1001 and is punishable by a fine of up to $10,000 or up to 5 years in prison.

The Agency for Healthcare Research and Quality requests that users cite AHRQ and the Medical Expenditure Panel Survey as the data source in any publications or research based upon these data.

Return To Table Of Contents

B. Background

1.0 Household Component

The Medical Expenditure Panel Survey (MEPS) provides nationally representative estimates of health care use, expenditures, sources of payment, and health insurance coverage for the U.S. civilian noninstitutionalized population. The MEPS Household Component (HC) also provides estimates of respondents’ health status, demographic and socio-economic characteristics, employment, access to care, and satisfaction with health care. Estimates can be produced for individuals, families, and selected population subgroups. The panel design of the survey includes five rounds of interviews covering two full calendar years. Additional rounds were added in 2020 and 2021, covering third and fourth years respectively, to compensate for the smaller number of completed interviews in later panels. These extra rounds provide data for examining person-level changes in selected variables such as expenditures, health insurance coverage, and health status. Using computer assisted personal interviewing (CAPI) technology, information about each household member is collected, and the survey builds on this information from interview to interview. All data for a sampled household are reported by a single household respondent.

The MEPS HC was initiated in 1996. Each year a new panel of sample households is selected. Because the data collected are comparable to those from earlier medical expenditure surveys conducted in 1977 and 1987, it is possible to analyze long-term trends. Each annual MEPS HC sample size is about 15,000 households. Data can be analyzed at either the person or event level. Data must be weighted to produce national estimates.

The set of households selected for each panel of the MEPS HC is a subsample of households participating in the previous year’s National Health Interview Survey (NHIS) conducted by the National Center for Health Statistics. The NHIS sampling frame provides a nationally representative sample of the U.S. civilian noninstitutionalized population. In 2006, the NHIS implemented a new sample design, which included Asian persons in addition to households with Black and Hispanic persons in the oversampling of minority populations. NHIS introduced a new sample design in 2016 that discontinued oversampling of these minority groups.

Return To Table Of Contents

2.0 Medical Provider Component

Upon completion of the household CAPI interview and obtaining permission from the household survey respondents, a sample of medical providers are contacted by telephone to obtain information that household respondents cannot accurately provide. This part of the MEPS is called the Medical Provider Component (MPC) and information is collected on dates of visits, diagnosis and procedure codes, charges and payments. The Pharmacy Component (PC), a subcomponent of the MPC, does not collect charges or diagnosis and procedure codes but does collect drug detail information, including National Drug Code (NDC) and medicine name, as well as amounts of payment. The MPC is not designed to yield national estimates. It is primarily used as an imputation source to supplement/replace household reported expenditure information.

Return To Table Of Contents

3.0 Survey Management and Data Collection

MEPS HC and MPC data are collected under the authority of the Public Health Service Act. Data are collected under contract with Westat, Inc. (MEPS HC) and Research Triangle Institute (MEPS MPC). Data sets and summary statistics are edited and published in accordance with the confidentiality provisions of the Public Health Service Act and the Privacy Act. The National Center for Health Statistics (NCHS) provides consultation and technical assistance.

As soon as data collection and editing are completed, the MEPS survey data are released to the public in staged releases of micro data files and tables via the MEPS website and datatools.ahrq.gov.

Additional information on MEPS is available from the MEPS project manager or the MEPS public use data manager at the Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD 20857 (301-427-1406).

Return To Table Of Contents

C. Technical and Programming Information

1.0 General Information

This documentation describes the data contained in MEPS Public Use Release HC-231, which is one in a series of public use data files to be released from the 2021 Medical Expenditure Panel Survey Household Component (MEPS HC). Released as an ASCII file (with related SAS, SPSS, R, and Stata programming statements and data user information), and a SAS data set, SAS transport file, Stata data set, and Excel file, this public use file provides information on household-reported medical conditions collected on a nationally representative sample of the civilian noninstitutionalized population of the United States for calendar year 2021 MEPS HC. The file contains 32 variables and has a logical record length of 113 with an additional 2-byte carriage return/line feed at the end of each record.

This documentation offers a brief overview of the types and levels of data provided and the content and structure of the files. It contains the following sections:

  • Data File Information

  • Survey Sample Information

  • Merging/Linking MEPS Data Files

  • Variable-Source Crosswalk

  • Appendix: ICD10CDX and CCSR Condition Code Frequencies

A codebook of all the variables included in the 2021 Medical Conditions File is provided in an accompanying file.

For more information on the MEPS sample design, see Chowdhury et al. (2019). A copy of the survey instrument used to collect the information on this file is available on the MEPS website.

Return To Table Of Contents

2.0 Data File Information

This file contains 94,641 records. Each record represents one current medical condition reported for a household survey member who resides in an eligible responding household and who has a positive person or family weight. A condition is defined as current if it is linked to an event during 2021. Conditions in the Priority Condition Enumeration (PE) section are asked in the context of “has person ever been told by a doctor or other health care professional that they have (condition)?” except joint pain and chronic bronchitis, which ask only about the last 12 months. Persons with a response of Yes (1) to a priority condition question for whom the condition is not current as defined above will not have a record for that condition in this file.

This file consists of MEPS survey data obtained in Rounds 7, 8, and 9 of Panel 23; Rounds 5, 6, and 7 of Panel 24; Rounds 3, 4, and 5 of Panel 25; and Rounds 1, 2, and 3 of Panel 26, the rounds for the MEPS panels covering calendar year 2021. 2021 is the first data year to include four panels of data; Panel 23 was extended to include Rounds 7, 8, and 9 and Panel 24 was extended to include Rounds 6 and 7. In addition, the Panel 24 Round 5 reference period was extended into 2021 instead of ending on 12/31/2020.

For most variables on the file, the codebook provides both weighted and unweighted frequencies. The exceptions to this are weight variables and variance estimation variables. Only unweighted frequencies of these variables are included in the accompanying codebook file. See the Weights Variables list in Section D, Variable-Source Crosswalk.

Person-level data (e.g., demographic or health insurance characteristics) from the 2021 MEPS Full Year Consolidated file (HC-233) can be merged to the records in this file using DUPERSID (see Section 4.0 for details). Since each record represents a single condition reported by a household respondent, some household members may have multiple medical conditions and thus will be represented by multiple records on this file. Other household members may have had no reported medical conditions and thus will have no records on this file. Still other household members may have had a reported medical condition that did not meet the criteria above and thus will have no records on this file. Data from this file also can be merged to 2021 MEPS Event Files (HC-229D through HC-229H) by using the link files provided in HC-229I. (See HC-229I documentation for details.)

Return To Table Of Contents

2.1 Codebook Structure

The codebook and data file list variables in the following order:

  • Unique person identifiers

  • Unique condition identifiers

  • Medical condition variables

  • Utilization variables

  • Weight and variance estimation variables

Note that the person identifier is unique within this data year.

Return To Table Of Contents

2.2 Reserved Codes

The following reserved code values are used:

Value Definition
-1 INAPPLICABLE Question was not asked due to skip pattern
-7 REFUSED Question was asked and respondent refused to answer question
-8 DK Question was asked and respondent did not know answer or the information could not be ascertained
-15 CANNOT BE COMPUTED Value cannot be derived from data

The value -15 (CANNOT BE COMPUTED) is assigned to MEPS constructed variables in cases where there is not enough information from the MEPS instrument to calculate the constructed variables. “Not enough information” is often the result of skip patterns in the data or from missing information resulting from MEPS responses of -7 (REFUSED) or -8 (DK). Note that reserved code -8 includes cases where the information from the question was “not ascertained” or where the respondent chose “don’t know”.

Return To Table Of Contents

2.3 Codebook Format

This codebook describes an ASCII data set (although the data are also being provided in an Excel file, a Stata data set, a SAS data set, and a SAS transport file), and provides the programming identifiers below for each variable:

Variable Programming Identifiers

Identifier Description
Name Variable name
Description Variable descriptor
Format Number of bytes
Type Type of data: numeric (indicated by NUM) or character (indicated by CHAR)
Start Beginning column position of variable in record
End Ending column position of variable in record

Return To Table Of Contents

2.4 Variable Naming

In general, variable names reflect the content of the variable, with an 8-character limitation. Edited variables end in an “X” and are so noted in the variable label. (CONDIDX, which is an encrypted identifier variable, also ends in an “X”.)

As variable collection, universe, or categories are altered, the variable name will be appended with “_Myy” to indicate in which year the alterations took place. Details about these alterations can be found throughout this document.

Variables contained in this delivery were derived either from the questionnaire itself or from the CAPI. The source of each variable is identified in Section D, Variable-Source Crosswalk. Sources for each variable are indicated in one of three ways: (1) variables derived from CAPI or assigned in sampling are so indicated; (2) variables collected at one or more specific questions have those numbers and questionnaire sections indicated in the “SOURCE” column; and (3) variables constructed from multiple questions using complex algorithms are labeled “Constructed” in the “SOURCE” column.

Return To Table Of Contents

2.5 File Contents

2.5.1 Identifier Variables (DUID-CONDRN)

The definitions of Dwelling Units (DUs) in the MEPS HC are generally consistent with the definitions employed for the National Health Interview Survey (NHIS). The Dwelling Unit ID (DUID) is a seven-digit ID number consisting of a 2-digit panel number followed by a five-digit random number assigned after the case was sampled for MEPS. A three-digit person number (PID) uniquely identifies each person within the DU. The variable DUPERSID is the combination of the variables DUID and PID. IDs begin with a 2-digit panel number.

CONDN is the condition number and uniquely identifies each condition reported for an individual. The range on this file for CONDN is 1-901. A CONDN beginning with “9” reflects a condition that was added during the editing process.

The variable CONDIDX uniquely identifies each condition (i.e., each record on the file) and is the combination of DUPERSID and CONDN. CONDIDX has a length of 13 with DUPERSID (10) and CONDN (3) combined.

PANEL is a constructed variable used to specify the panel number for the interview in which the condition was reported. PANEL will indicate Panel 23, Panel 24, Panel 25, or Panel 26. The panel number is included as the first two digits of the DUID and DUPERSID.

CONDRN indicates the round in which the condition was first reported. For a small number of cases, conditions that actually began in an earlier round were not reported by respondents until subsequent rounds of data collection. During file construction, editing was performed for these cases in order to reconcile the round in which a condition began and the round in which the condition was first reported.

Return To Table Of Contents

2.5.2 Medical Condition Variables (AGEDIAG-ICD10CDX)

This file contains variables describing medical conditions reported by respondents in several sections of the MEPS questionnaire, and all questionnaire sections collecting information about health provider visits and/or prescription medications (see Variable-Source Crosswalk in Section D for details).

Priority Conditions and Injuries

Certain conditions were a priori designated as “priority conditions” due to their prevalence, expense, or relevance to policy. Some of these are long-term, life-threatening conditions, such as cancer, diabetes, emphysema, high cholesterol, hypertension, ischemic heart disease, and stroke. Others are chronic, manageable conditions, including arthritis and asthma. The only mental health condition on the priority conditions list is attention deficit hyperactivity disorder/attention deficit disorder.

When a condition was first mentioned, respondents were asked whether it was due to an accident or injury (INJURY=1). Only non-priority conditions (i.e., conditions reported in a section other than PE) are eligible to be injuries. The interviewer is prevented from selecting priority conditions as injuries.

Complete List of Conditions Asked in Priority Conditions Enumeration Section:

Angina/Angina Pectoris

Arthritis

Asthma

Attention Deficit Hyperactivity Disorder (ADHD)/Attention Deficit Disorder (ADD)

Cancer/Malignancy

Chronic Bronchitis

Coronary Heart Disease

Diabetes/Sugar Diabetes

Emphysema

Heart Attack/Myocardial Infarction (MI)

High Cholesterol

Hypertension/High Blood Pressure

Joint Pain

Other Heart Disease (not coronary heart disease, angina, or heart attack)

Stroke/Transient Ischemic Attack (TIA)/Mini-stroke

Age Priority Condition Began

The age of diagnosis (AGEDIAG) was collected for all priority conditions, except joint pain. For confidentiality reasons, AGEDIAG is set to Inapplicable (-1) for cancer conditions.

To ensure confidentiality, age of diagnosis was top-coded to 85. This corresponds with the age top-coding in person-level PUFs.

Follow-up Questions for Injuries

When a respondent reported that a condition resulted from an accident or injury (INJURY=1), respondents were asked during the round in which the injury was first reported whether the accident/injury occurred at work (ACCDNWRK). This question was not asked about persons aged 15 and younger; the condition had ACCDNWRK coded to inapplicable (-1) for those persons.

Sources for Conditions on the MEPS Conditions File

The records on this file correspond with medical condition records collected by CAPI and stored on a person’s MEPS conditions roster. Conditions can be added to the MEPS conditions roster in several ways. A condition can be reported in the Priority Condition Enumeration (PE) section in which persons are asked if they have been diagnosed with specific conditions. The condition can be identified as the reason reported by the household respondent for a particular medical event (hospital stay, outpatient visit, emergency room visit, home health episode, prescribed medication purchase, or office-based medical provider visit). Some condition information is collected in the Medical Provider Component of MEPS. However, since it is not available for everyone in the sample, it is not used to supplement, replace, or verify household-reported condition data. Conditions reported in the PE section that are not current are not included on this file.

Treatment of Data from Rounds Not Occurring in 2021

Prior to the 2008 file, priority conditions reported during Rounds 1 and 2 of the second year panel were included on the file even if the conditions were not related to an event or reported as a serious condition occurring in the second year of the panel. Beginning in 2008, priority conditions are included on the file only if they are also current conditions. From 2008-2017, a current condition was defined as a condition linked to an event or a condition the person was currently experiencing (i.e., a condition selected in the Condition Enumeration (CE) section). However, starting in Panel 21 Round 5 and Panel 22 Round 3, a current condition is defined only as a condition linked to a current year event. Conditions from Panel 23 Rounds 6 and 7 as well as Panel 24 Rounds 3-5 and Panel 25 Rounds 1-3 that are not included in the 2021 file may be available in the 2020 Medical Conditions File if the person had a positive person or family weight in 2020.

Note: Priority conditions are generally chronic conditions. Even though a person may not have reported an event in 2021 due to the condition, analysts should consider that the person may still be experiencing the condition. If a Panel 25 person reported a priority condition in Round 1 or 2 and did not have an event for the condition in Round 3, 4, or 5, the condition will not be included on the 2021 Medical Conditions File. Similarly: if a Panel 24 person reported a priority condition in Round 1, 2, 3, or 4 and did not have an event for the condition in Round 5, 6, or 7, or if a Panel 23 person reported a priority condition in Round 1, 2, 3, 4, 5, or 6 and did not have an event for the condition in Round 7, 8, or 9, the condition will not be included on the 2021 Medical Conditions File.

Rounds in Which Conditions Were Reported/Selected (CRND1 - CRND9)

A set of constructed variables indicates the round in which the condition was first reported (CONDRN), and the subsequent round(s) in which the condition was selected (CRND1 - CRND9). The condition may be reported or selected when the person reports an event that occurred due to the condition. For example, consider a condition for which CRND1 = 0, CRND2 = 1, and CRND3 = 1. For non-priority conditions (conditions not asked in the PE section), this sequence of indicators on a condition record implies that the condition was not present during Round 1 (CRND1 = 0), was first mentioned during Round 2 (CRND2 = 1, CONDRN = 2), and was selected again during Round 3 (CRND3 = 1). For priority conditions, this sequence of indicators implies that the condition was reported in the PE section in Round 1 (CONDRN = 1, CRND1 = 0) but was not connected with an event until Rounds 2 and 3 (CRND2 = 1, CRND3 = 1). Because priority conditions are asked in the context of “has person ever been told by a doctor or other health care professional that they have (condition)?” except joint pain and chronic bronchitis, which ask only about the last 12 months, a priority condition might not be selected in the round in which it was first reported. A condition is current if it is linked to an event that occurred in 2021.

Diagnosis Codes

Medical conditions reported by the Household Component respondent were recorded by the interviewer using a condition pick-list with ICD-10-CM codes already assigned to conditions in the list. Reported conditions not in the pick-list were recorded as verbatim text and then were coded to ICD-10-CM codes (ICD10CDX) by professional coders.

Coders followed specific guidelines in coding missing values to the ICD-10-CM diagnosis condition variable when a verbatim text string could not be matched to an ICD-10-CM code through the pick-list. ICD10CDX was coded -15 (Cannot be Computed) where the verbatim text fell into one of three categories: (1) the text indicated that the condition was unknown (e.g., DK); (2) the text indicated the condition could not be diagnosed by a doctor (e.g., doctor doesn’t know); or (3) the specified condition was not codable. If the text indicated a procedure and the condition associated with the procedure could be discerned from the text, the condition itself is coded. For example, “cataract surgery” is coded as the condition “other cataract” (ICD10CDX is set to code “H26”). If the condition could not be discerned (e.g. “outpatient surgery”), ICD10CDX is set to -15.

In order to preserve confidentiality, all of the conditions provided on this file have been collapsed to 3-digit diagnosis code categories rather than the fully-specified ICD-10-CM code. For example, the ICD10CDX value of J02 “Acute pharyngitis” includes the fully-specified subclassifications J020 and J029; the value F31 “Bipolar disorder” includes the fully-specified subclassifications F3110 through F319. Table 1 in Appendix 1 provides unweighted and weighted frequencies for all ICD-10-CM condition code values reported on the file. Less than 1 percent of the ICD-10-CM codes on this file were edited further by collapsing two or more 3-digit codes into one 3-digit code. This includes clinically rare conditions that were recoded to broader codes by clinicians. A condition is determined to be clinically rare if it appears on the National Institutes of Health’s list of rare diseases.

For confidentiality purposes, approximately 7% of ICD-10-CM codes were recoded to -15 (Cannot be Computed) for conditions where the frequency was fewer than 40 for the total unweighted population in the file or less than 400,000 for the weighted population. Additional factors used to determine recoding include age and gender.

In a small number of cases, diagnosis and condition codes were recoded to -15 (Cannot be Computed) if they denoted a pregnancy for a person younger than 18 or older than 44. Less than one-tenth of 1 percent of records were recoded in this manner on the 2021 Medical Conditions file. The person’s age was determined by linking the 2021 Medical Conditions file to the 2020 and 2021 Population Characteristics File. If the person’s age is under 18 or over 44 in the round in which the condition was reported, the appropriate condition code was recoded to -15 (Cannot be Computed).

Users should note that because of the design of the survey, most deliveries (i.e., births) are coded as pregnancies. For more accurate estimates for deliveries, analysts should use RSNINHOS “Reason Entered Hospital” found on the Hospital Inpatient Stays Public Use File (HC-229D).

Each year, a few conditions on the final file may fall below the confidentiality threshold. This is due to the multistage file development process. The confidentiality recoding is performed on the preliminary version of the Conditions file each year. This preliminary version is used in the development of other event PUFs and, in turn, these event PUFs are used in the development of the final Conditions file. During this process, some records from the preliminary file are dropped because only records that are relevant to the current data year are reflected in the final Conditions PUF.

Conditions file data can be merged with the 2021 MEPS Event Files using the 2021 MEPS Condition-Event Linking file (HC-229I). Because the conditions have been collapsed to 3-digit diagnosis code categories rather than the fully-specified ICD-10-CM code, it is possible for there to be duplicate ICD-10-CM condition codes linked to a single medical event when different fully-specified conditions are coded to the same 3-digit code.

Conditions were reported in several sections of the HC questionnaire (see Variable-Source Crosswalk in Section D). Labels for all values of ICD10CDX, as shown in Table 1 of Appendix 1, are provided in the SAS programming statements included in this release (see the H231SU.TXT file).

Clinical Classification Software Refined

Clinical Classification Software Refined (CCSR) are used alongside ICD-10-CM diagnosis codes to group medical conditions into clinically meaningful categories. Although ICD-10-CM diagnosis codes can map to multiple CCSR codes, for the purposes of this PUF, one ICD-10-CM diagnosis code may map to up to three CCSR categories (CCSR1X, CCSR2X, CCSR3X) using the v2022.2 release of the CCSR for ICD-10-CM diagnoses. The CCSR categories on this PUF are listed in alphabetical order and do not indicate a primary and secondary diagnosis. For more information on CCSR, visit the user guide for CCSR.

For confidentiality purposes, less than 2% of the CCSR categories were collapsed into a broader code for the appropriate body system where the frequency was less than 40 for the total unweighted population in the file or less than 400,000 for the weighted population. For example, BLD001 (Nutritional Anemia), may be recoded to BLD000 (Disease of Blood and Disorders Involving Immune Mechanism), thus revealing only the body system. Less than 1% of CCSR codes were recoded to -15 (Cannot be Computed) based on frequencies of ICD10CDX and CCSR pairs.

Table 2 in Appendix 1 provides unweighted and weighted frequencies for CCSR combinations reported on the file.

Return To Table Of Contents

2.5.3 Utilization Variables (OBCOND - RXCOND)

The variables OBCOND, OPCOND, HHCOND, IPCOND and ERCOND indicate that at least one 2021 event can be linked to each condition record on the current file, i.e., office-based, outpatient, home health, inpatient hospital stays and emergency room visits. Note that the HHCOND variable includes all home health types, including informal care, and OBCOND and OPCOND include telehealth visits. The variable RXCOND is an indicator of any prescribed medicine purchase associated with the condition.

These event indicators were derived from Expenditure Event Public Use Files (HC-229G, HC-229F, HC-229H, HC-229D, and HC-229E). Events associated with conditions include all utilization that occurred between January 1, 2021 and December 31, 2021.

Return To Table Of Contents

3.0 Survey Sample Information

3.1 Discussion of Pandemic Effects on Quality of 2021 MEPS Data

3.1.1 Summary

The challenges associated with MEPS data collection in 2020 after the onset of the COVID-19 pandemic continued into 2021. The major modifications to the standard MEPS study design remained in effect, permitting data to be collected safely but with accompanying concerns related to the quality of the data obtained. These data quality issues are discussed below. The suggestion made in the documentation for the 2020 MEPS Full Year Consolidated PUF data (as well as for most federal major in-person surveys conducted in 2021 and 2020) still holds. Researchers are counseled to take care in the interpretation of estimates based on data collected from these two calendar years. This includes the comparison of such estimates to those of other years and corresponding trend analyses.

Return To Table Of Contents

3.1.2 Overview

Section 3.1 of the documentation for the 2020 Full Year Consolidated Data File provides a general discussion of the impact of the COVID-19 pandemic on several other major in-person federal surveys as well as on MEPS. In addition, it offers a detailed look at how MEPS was modified to permit safe data collection and the development of useful estimates at a time when the way the U.S. health care system functioned underwent many transformations in order to meet population needs.

In this corresponding 2021 document, focus is placed mostly on MEPS data quality in 2021. However, it also includes how data quality issues related to the two federal surveys most closely connected to it, the National Health Interview Survey (NHIS) carried out by the National Center for Health Statistics (NCHS) and the Current Population Survey (CPS) carried out by the Census Bureau, have an impact on the data quality issues of MEPS.

Specifically, the following discussion describes: 1) data quality issues experienced by the NHIS and CPS that affect MEPS; 2) modifications to the MEPS sample design in 2021 due to the continuing pandemic; and 3) potential data quality issues in the FY 2021 MEPS data related to the COVID-19 pandemic.

Return To Table Of Contents

3.1.3 Data Quality Issues for MEPS in 2021 Directly Associated with Data Quality Concerns for the NHIS and CPS

Households fielded for Round 1 of MEPS in each year have been selected as a subsample from among the NHIS responding households from the prior year. The MEPS first year panel in 2021 was Panel 26. The households fielded for MEPS in Round 1 of Panel 26 were thus selected from NHIS responding households in 2020. It is important to note here that the NHIS households eligible for use in MEPS are restricted to the first three quarters of the NHIS as the fourth quarter households cannot be made available in time for MEPS data collection early in the next calendar year.

The onset of the pandemic in 2020 at a national level took place in mid-March of that year, when the NHIS data collection for the first quarter of 2020 was virtually completed and that of the second quarter was about to begin. The NHIS had to make a rapid transition from in-person to telephone interviewing to attempt to gather NHIS data for the second quarter of 2020. While NCHS was able to make the transition, assessments made by NCHS at the time indicated a much lower response rate than is typically experienced during Quarter 2 and the quality of Quarter 2 data was of particular concern. NCHS thus modified the 2020 NHIS sample design for Quarters 3 and 4. A randomly selected subsample of the sampled housing units originally selected for fielding in Quarters 3 and 4 of 2020 was removed from the sample to be fielded. This reduced sample for Quarters 3 and 4 was then enhanced by randomly selecting responding households from the 2019 NHIS for interviewing in 2020 as well. In consideration of the data quality issues and sample design modifications associated with the 2020 NHIS, the MEPS sample design for FY 2021 was modified, as discussed shortly below.

The quality of CPS data is always of particular importance to MEPS as March CPS-ASEC estimates serve as the basis of control totals for the raking component of the MEPS weighting process. These control totals incorporate the following demographic variables: age, sex, race/ethnicity, region, MSA status, educational attainment, and poverty status. The CPS estimates of educational attainment and poverty status used in the development of the FY 2021 MEPS PUFs were of particular concern. Evaluations of these estimates undertaken by the Census Bureau have shown that they suffered from bias due to survey nonresponse with CPS income estimates being on the high side and the estimate of those under the poverty threshold being on the low side. The impact of these CPS estimates on the quality of MEPS estimates has been carefully considered. The approach used for the 2021 MEPS Full Year Consolidated PUF sample weights is discussed in Section 3.3.

References (Bramlett et al., 2021; Dahlhamer et al., 2021; Lau et al, 2021; Rothbaum & Bee, 2021, 2022; Zuvekas & Kashihara, 2021) discussing the fielding of these surveys during the pandemic and possible bias concerns, can be found in the References section of this document.

Return To Table Of Contents

3.1.4 Modifications to the MEPS HC 2021 Sample Design

The MEPS sample is usually selected from Quarters 1 to 3 of NHIS Panels 1 and 3. However, 2020 NHIS Quarter 2 data quality and sample size issues needed to be considered in planning for selecting and fielding a MEPS sample for 2021. It became clear that it would be prudent to modify the 2021 MEPS sample design for MEPS Panel 26 by replacing 2020 NHIS Quarter 2 with another quarter from 2020 NHIS Panels 2 and 4. Action had to be taken immediately because the MEPS sample selection from NHIS responding households begins in the late summer/early fall of each year.

AHRQ contacted NCHS, reviewing the various issues and asking if responding households in NHIS Panels 2 and 4 from Quarter 1 of 2020 could be made available for MEPS sample selection. Virtually all of these households were interviewed in-person prior to the major onset of the pandemic, so the Quarter 1 response rates for all four NHIS panels were consistent with prior years and the data quality issues associated with the pandemic could be avoided. NCHS was fully supportive of this approach and made NHIS Panels 2 and 4 for Quarter 1 available for use by MEPS. Thus, for MEPS Panel 26, the NHIS responding households subsampled for MEPS were selected among all NHIS responding households in all four NHIS panels in Quarter 1 as well as those responding in Quarter 3 of NHIS Panels 1 and 3.

As an adjunct to this modification, it was decided to take advantage of the additional PSUs (sampled localities) available from NHIS Panels 2 and 4 and appearing in the MEPS sample for the first time. State level estimation is of interest to MEPS, and the added PSUs would serve to increase the precision of variance estimation for state level estimates. State estimates that would be expected to benefit the most from these added PSUs were the “middle-sized” states where sample sizes were marginal but usually not enough PSUs for variance estimation. The largest states already had large sample sizes while precision for the smallest states would remain low. As a result, from Quarter 1 of 2020 NHIS Panels 2 and 4, the MEPS sample focused on oversampling the “middle-sized” states rather than Asians, Blacks, and Hispanics.

Finally, it was decided to collect 2021 data for nine rounds of Panel 23 and seven rounds of Panel 24, so that these two panels will contribute to MEPS estimates for four calendar years for Panel 23 and three calendar years for Panel 24. In so doing, the number of respondents to MEPS will be kept at a relatively high level despite the decline in response rates due to the pandemic. The MEPS FY 2021 PUF records thus consist of data obtained from the following MEPS Panels and corresponding rounds: Panel 23, Rounds 7-9; Panel 24, Rounds 5-7; Panel 25, Rounds 3-5; and Panel 26, Rounds 1-3.

Return To Table Of Contents

3.1.5 Data Quality Issues for MEPS for FY 2021

Three sources of potential bias were identified for MEPS for FY 2020: long recall period for Round 6 of Panel 23; switching from in-person to telephone interviewing which likely had a larger impact on Panel 25; and the impact of CPS bias on the MEPS weights. A number of statistically significant differences were found between panels for FY 2020. Those findings are discussed in the documentation for the 2020 Full Year Consolidated PUF.

With this in mind, there were a number of uncertainties for FY 2021 warranting examination. Would Panel 23 data quality increase substantially once the issue of an extensive recall period was eliminated? Would the switching from in-person to telephone interview in Round 1 continue to impact Panel 25 estimates? Since Panel 26 was the first year MEPS panel in 2021, would Panel 26 estimates tend to be different than those of the other three panels?

Analyses undertaken to examine the quality of MEPS FY 2021 data appearing on the Consolidated PUF have been focused on the comparison of health care utilization and health insurance status distribution (some private insurance, some public insurance, no health insurance) for the MEPS target population between the panels fielded. These comparisons were undertaken for the full sample and the three age groups of 0-17, 18-64, and 65+.

Comparisons of health care utilization data for Panel 24 and Panel 23 found no statistically significant differences in any of the analysis variables, suggesting that Panel 23 data quality increased substantially once the issue of an extensive recall period was eliminated. Comparisons of Panel 26 and Panel 24 health care utilization data did not detect any notable differences among event types of a salient nature.

Similar to FY 2020, comparisons of Panel 25 health care utilization data with those from other panels found that the difference in estimates reached statistical significance for several event types, with those from Panel 25 generally being higher. However, the gap between the Panel 25 estimates and other panels has shown a sizeable decrease, suggesting that the Panel 25 data quality has improved.

Another set of analyses compared estimates based on the four panels pooled together using the FY 2021 Consolidated PUF weight compared to the estimates based on the individual panel data and weights. Analyses indicated that event estimates combining data from all four panels show little difference from event estimates of the individual panels.

The analyses undertaken for health insurance status distribution suggest no major differences between the four panels for the various event type estimates. Even though slight differences were observed with Panel 25 (e.g., the distribution associated with the age range 18-64 showed a higher percentage of all public insurance compared to the other three panels while those at least 65 years of age showed a lower percentage of some private insurance compared to the other three panels), no statistically significant differences were detected.

Return To Table Of Contents

3.1.6 Discussion and Guidance

The various actions taken in the development of the person-level weights for the MEPS FY 2021 Consolidated PUF were designed to limit the potential for bias in the data due to changes in data collection and response bias. However, evaluations of MEPS data quality in 2021, consistent with those of other Federal surveys fielded in 2021, suggest that users of the MEPS FY 2021 Consolidated PUF should exercise caution when interpreting estimates and assessing analyses based on these data as well as in comparing 2021 estimates to those of prior years.

Return To Table Of Contents

3.2 Sample Weight (PERWT21F)

There is a single full-year person-level weight (PERWT21F) assigned to each record for each key, in-scope person who responded to MEPS for the full period of time that they were in-scope during 2021. A key person was either a member of a responding NHIS household at the time of the interview or joined a family associated with such a household after being out-of-scope at the time of the NHIS (the latter circumstance includes newborns as well as those returning from military service, an institution, or residence in a foreign country). A person is in-scope whenever they are a member of the civilian, noninstitutionalized portion of the U.S. population.

Return To Table Of Contents

3.3 Details on Person Weight Construction

The person-level weight PERWT21F was developed in several stages. Preliminary person-level weights for Panel 23, Panel 24, Panel 25, and Panel 26 were first created separately. The weighting process for each panel included an adjustment for nonresponse over time and calibration to independent population figures. The calibration was initially accomplished separately for each panel by raking the corresponding sample weights for those in-scope at the end of the calendar year to Current Population Survey (CPS) population estimates based on six variables. The six variables used in the establishment of the person-level control figures were: educational attainment of the reference person (no degree, high school/GED no college or some college, bachelor’s degree or higher); census region (Northeast, Midwest, South, West); MSA status (MSA, non-MSA); race/ethnicity (Hispanic; Black, non-Hispanic; Asian, non-Hispanic; and other); sex; and age. A composite weight was then formed by multiplying each weight from Panel 23 by the factor .22, each weight from Panel 24 by the factor .22, each weight from Panel 25 by the factor .25, and each weight from Panel 26 by the factor .31. The choice of factors reflected the relative effective sample sizes of the four panels, helping to limit the variance of estimates obtained from pooling the four samples. Weights for the 2021 Full Year Population Characteristics PUF were then developed by raking the composite weight to the same set of CPS-based control totals.

The standard approach for establishing the 2021 Full Year Consolidated PUF weight is as follows. When the poverty status information derived from income variables becomes available, a final raking is undertaken. The full sample weight appearing on the Population Characteristics PUF for a given year is re-raked, establishing control figures reflecting poverty status rather than educational attainment. Thus, control totals are established using poverty status (five categories: below poverty, from 100 to 125 percent of poverty, from 125 to 200 percent of poverty, from 200 to 400 percent of poverty, at least 400 percent of poverty) as well as the other five variables previously used in the weight calibration.

Return To Table Of Contents

3.3.1 MEPS Panel 23 Weight Development Process

The person-level weight for MEPS Panel 23 was developed using the 2020 full-year weight for an individual as a “base” weight for 2020 survey participants present in 2021. For key, in-scope members who joined an RU some time in 2021 after being out-of-scope in 2020, the initially assigned person-level weight was the corresponding 2020 family weight. The weighting process included an adjustment for person-level nonresponse over Rounds 8 and 9 as well as raking to population control figures for December 2021 for key, responding persons in-scope on December 31, 2021. These control totals were derived by scaling back the population distribution obtained from the March 2022 CPS to reflect the December 31, 2021 estimated population total (estimated based on Census projections for January 1, 2022). Variables used for person-level raking included: education of the reference person (three categories: no degree; high school/GED only or some college; Bachelor’s or higher degree); Census region (Northeast, Midwest, South, West); MSA status (MSA, non-MSA); race/ethnicity (Hispanic; Black, non-Hispanic; Asian, non-Hispanic; and other); sex; and age. (It may be noted that for confidentiality reasons, the MSA status variables are no longer released for public use.) The final weight for key, responding persons who were not in-scope on December 31, 2021 but were in-scope earlier in the year was the nonresponse-adjusted person weight without raking.

The 2020 full-year weight used as the base weight for Panel 23 was derived from the 2018 MEPS Round 1 weight and reflected adjustment for nonresponse over the remaining data collection rounds in 2018, 2019, and 2020 as well as raking to the December 2018, December 2019, and December 2020 population control figures.

Return To Table Of Contents

3.3.2 MEPS Panel 24 Weight Development Process

The person-level weight for MEPS Panel 24 was developed using the 2020 full-year weight for an individual as a “base” weight for survey participants present in 2021. For key, in-scope members who joined an RU some time in 2021 after being out-of-scope in 2020, the initially assigned person-level weight was the corresponding 2020 family weight. The weighting process included an adjustment for person-level nonresponse over Rounds 6 and 7 as well as raking to the same population control totals for December 2021 used for the MEPS Panel 23 weights for key, responding persons in-scope on December 31, 2021. The same six variables employed for Panel 23 raking (education level, census region, MSA status, race/ethnicity, sex, and age) were also used for Panel 24 raking. Similar to Panel 23, the Panel 24 final weight for key, responding persons not in-scope on December 31, 2021 but in-scope earlier in the year was the nonresponse-adjusted person weight without raking.

Note that the 2020 full-year weight that was used as the base weight for Panel 24 was derived using the 2019 MEPS Round 1 weight and reflected adjustment for nonresponse over the remaining data collection rounds in 2019 and 2020 as well as raking to the December 2019 and December 2020 population control figures.

Return To Table Of Contents

3.3.3 MEPS Panel 25 Weight Development Process

The person-level weight for MEPS Panel 25 was developed using the 2020 full-year weight for an individual as a “base” weight for survey participants present in 2021.

For key, in-scope members who joined an RU sometime in 2021 after being out-of-scope in 2020, the initially assigned person-level weight was the corresponding 2020 family weight. The weighting process also included an adjustment for person-level nonresponse over Rounds 4 and 5 as well as raking to the same population control figures for December 2021 used for the MEPS Panels 23 and 24 weights for key, responding persons in-scope on December 31, 2021. The same six variables employed for Panels 23 and 24 raking (education level, census region, MSA status, race/ethnicity, sex, and age) were also used for Panel 25 raking. Similar to Panels 23 and 24, the Panel 25 final weight for key, responding persons not in-scope on December 31, 2021 but in-scope earlier in the year was the nonresponse-adjusted person weight without raking.

Note that the 2020 full-year weight that was used as the base weight for Panel 25 was derived using the 2020 MEPS Round 1 weight and reflected adjustment for nonresponse over the remaining data collection rounds in 2020 as well as raking to the December 2020 population control figures.

Return To Table Of Contents

3.3.4 MEPS Panel 26 Weight Development Process

The person-level weight for MEPS Panel 26 was developed using the 2021 MEPS Round 1 person-level weight as a “base” weight. The MEPS Round 1 weights incorporated the following components: the original household probability of selection for the NHIS adjusted to reflect the NHIS subsample reserved for MEPS and an adjustment for NHIS nonresponse, the probability of selection for MEPS from NHIS, an adjustment for nonresponse at the dwelling unit level for Round 1, and poststratification to control figures at the person level obtained from the March CPS of 2021. For key, in-scope members who joined an RU after Round 1, the Round 1 DU weight served as a “base” weight.

The weighting process also included an adjustment for nonresponse over the remaining data collection rounds in 2021 as well as raking to the same population control figures for December 2021 used for the MEPS Panel 23, Panel 24, and Panel 25 weights for key, responding persons in-scope on December 31, 2021. The same six variables employed for Panel 23, Panel 24, and Panel 25 raking (education level of the reference person, census region, MSA status, race/ethnicity, sex, and age) were also used for Panel 26 raking. Similar to Panel 23, Panel 24, and Panel 25, the Panel 26 final weight for key, responding persons who were not in-scope on December 31, 2021 but were in-scope earlier in the year was the nonresponse-adjusted person weight without raking.

Return To Table Of Contents

3.3.5 The Final Weight for 2021

The final raking of those in-scope at the end of the year has been described above. In addition, the composite weights of two groups of persons who were out-of-scope on December 31, 2021 were adjusted for expected undercoverage. Specifically, the weights of those who were in-scope some time during the year, out-of-scope on December 31, and entered a nursing home during the year and still residing in a nursing home at the end of the year were poststratified to an estimate of the number of persons who were residents of Medicare- and Medicaid-certified nursing homes for part of the year (approximately 3-9 months) during 2014. This estimate was developed from data on the Minimum Data Set (MDS) of the Center for Medicare and Medicaid Services (CMS). The weights of persons who died while in-scope were poststratified to corresponding estimates derived using data obtained from the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), Underlying Cause of Death, 2018-2021 on CDC WONDER Online Database, released in 2023, the latest available data at the time. Separate decedent control totals were developed for the “65 and older” and “under 65” civilian noninstitutionalized populations.

Overall, the weighted population estimate for the civilian noninstitutionalized population for December 31, 2021 is 327,209,772 (PERWT21F >0 and INSC1231=1). The sum of person-level weights across all persons assigned a positive person-level weight is 331,249,393.

Return To Table Of Contents

3.4 Coverage

The target population for MEPS in this file is the 2021 U.S. civilian, noninstitutionalized population. However, the MEPS sampled households are a subsample of the NHIS households interviewed in 2017 (Panel 23), 2018 (Panel 24), 2019 (Panel 25), and 2020 (Panel 26). New households created after the NHIS interviews for the respective panels and consisting exclusively of persons who entered the target population after 2017 (Panel 23), after 2018 (Panel 24), after 2019 (Panel 25), or after 2020 (Panel 26) are not covered by MEPS. Neither are previously out-of-scope persons who join an existing household but are unrelated to the current household residents. Persons not covered by a given MEPS panel thus include some members of the following groups: immigrants; persons leaving the military; U.S. citizens returning from residence in another country; and persons leaving institutions. Those not covered represent a small proportion of the MEPS target population.

Return To Table Of Contents

3.5 Using MEPS Data for Trend Analysis

First, of course, we note that there are uncertainties associated with 2020 and 2021 data quality as discussed earlier in the data quality section (Section 3.1). Evaluations of important MEPS estimates suggest that they are of reasonable quality. Nevertheless, analysts are advised to exercise caution in interpreting these estimates, particularly in terms of trend analyses since access to health care was substantially affected by the COVID-19 pandemic as were related factors such as health insurance and employment status for many people.

MEPS began in 1996, and the utility of the survey for analyzing health care trends expands with each additional year of data; however, when examining trends over time using MEPS, the length of time being analyzed should be considered. In particular, large shifts in survey estimates over short periods of time (e.g. from one year to the next) that are statistically significant should be interpreted with caution unless they are attributable to known factors such as changes in public policy, economic conditions, or MEPS survey methodology.

With respect to methodological considerations, in 2013 MEPS introduced an effort focused on field procedure changes such as interviewer training to obtain more complete information about health care utilization from MEPS respondents with full implementation in 2014. This effort likely resulted in improved data quality and a reduction in underreporting starting in the second half of 2013 and throughout 2014 full year files and have had some impact on analyses involving trends in utilization across years. The changes in the NHIS sample design in 2016 and 2018 could also potentially affect trend analyses. The new NHIS sample design is based on more up-to-date information related to the distribution of housing units across the U.S. As a result, it can be expected to better cover the full U.S. civilian, noninstitutionalized population, the target population for MEPS, as well as many of its subpopulations. Better coverage of the target population helps to reduce the potential for bias in both NHIS and MEPS estimates.

A significant change to the Conditions file occurred in 2016 when ICD-10-CM condition codes replaced ICD-9-CM codes. As a result of this transition, CCS codes were replaced with CCSR codes. Up to three CCSR codes can be assigned to a single condition on this file; previously, a single CCS code was assigned to each condition (see Section 2.5.2 for details). Also in 2018, the inclusion criteria for conditions changed; therefore, fewer conditions are on the 2018 and later files compared to previous years. See section 2.0 for a discussion of conditions included on the file.

Another change with the potential to affect trend analyses involved major modifications to the MEPS instrument design and data collection process, particularly in the events sections of the instrument. These were introduced in the Spring of 2018 and thus affected data beginning with Round 1 of Panel 23, Round 3 of Panel 22, and Round 5 of Panel 21. Since the Full Year 2017 PUFs were established from data collected in Rounds 1-3 of Panel 22 and Rounds 3-5 of Panel 21, they reflected two different instrument designs. In order to mitigate the effect of such differences within the same full year file, the Panel 22 Round 3 data and the Panel 21 Round 5 data were transformed to make them as consistent as possible with data collected under the previous design. The changes in the instrument were designed to make the data collection effort more efficient and easy to administer. In addition, expectations were that data on some items, such as those related to health care events, would be more complete with the potential of identifying more events. Increases in service use reported since the implementation of these changes are consistent with these expectations. Data users should be aware of possible impacts on the data and especially trend analyses for these data years due to the design transition.

Process changes, such as data editing and imputation, may also affect trend analyses. For example, users should refer to Section 2.5.11 in the 2021 Full Year Consolidated file (HC-233) and, for more detail, the documentation for the prescription drug file (HC-229A) when analyzing prescription drug spending over time.

As always, it is recommended that data users review relevant sections of the documentation for descriptions of these types of changes that might affect the interpretation of changes over time before undertaking trend analyses.

Analysts may also wish to consider using statistical techniques to smooth or stabilize analyses of trends using MEPS data such as comparing pooled time periods (e.g. 1996-1997 versus 2011-2012), working with moving averages or using modeling techniques with several consecutive years of MEPS data to test the fit of specified patterns over time.

Finally, statistical significance tests should be conducted to assess the likelihood that observed trends are not attributable to sampling variation. In addition, researchers should be aware of the impact of multiple comparisons on Type I error. Without making appropriate allowance for multiple comparisons, undertaking numerous statistical significance tests of trends increases the likelihood of concluding that a change has taken place when one has not.

Return To Table Of Contents

4.0 National Health Interview Survey (NHIS)

Data from this file can be used alone or in conjunction with other files for different analytic purposes. Each MEPS panel can also be linked back to the previous years’ National Health Interview Survey public use data files. For information on MEPS/NHIS link files please see the AHRQ website.

Return To Table Of Contents

5.0 Longitudinal Analysis

Panel-specific longitudinal files are available for downloading in the data section of the MEPS website. For all four panels (Panel 23, Panel 24, Panel 25, and Panel 26), the longitudinal file comprises MEPS survey data obtained in all rounds of the panel and can be used to analyze changes over the entire length of the panel. For Panel 24, a file representing a three-year period will also be established and updated to cover four years with the release of 2022 data. For Panel 23, a file representing a four-year period will be established. Variables in the file pertaining to survey administration, demographics, employment, health status, disability days, quality of care, patient satisfaction, health insurance, and medical care use and expenditures were obtained from the MEPS full-year Consolidated files from the years covered by each panel. For more details or to download the data files, please see Longitudinal Data Files at the AHRQ website.

Return To Table Of Contents

References

Bramlett, M.D., Dahlhamer, J.M., & Bose, J. (2021, September). Weighting Procedures and Bias Assessment for the 2020 National Health Interview Survey.Centers for Disease Control and Prevention.

Chowdhury, S.R., Machlin, S.R. & Gwet, K.L. Sample Designs of the Medical Expenditure Panel Survey Household Component, 1996-2006 and 2007-2016. Methodology Report #33. January 2019. Agency for Healthcare Research and Quality, Rockville, MD.

Cox, B. and Iachan, R. (1987). A Comparison of Household and Provider Reports of Medical Conditions. Journal of the American Statistical Association 82(400): 1013-18.

Current Population Survey: 2021 Annual Social and Economic (ASEC) Supplement. (2021). U.S. Census Bureau.

Dahlhamer, J.M., Bramlett, M.D., Maitland, A., & Blumberg, S.J. (2021). Preliminary evaluation of nonresponse bias due to the COVID-19 pandemic on National Health Interview Survey estimates, April-June 2020. National Center for Health Statistics.

Edwards, W. S., Winn, D. M., Kurlantzick, V., et al. Evaluation of National Health Interview Survey Diagnostic Reporting. National Center for Health Statistics, Vital Health 2(120). 1994.

Health Care Financing Administration (1980). International Classification of Diseases, 9th Revision, Clinical Modification (ICD-CM). Vol. 1. (Department of Health and Human Services Pub. No (PHS) 80-1260). Department of Health and Human Services: U.S. Public Health Services.

Johnson, Ayah E., and Sanchez, Maria Elena. (1993), “Household and Medical Reports on Medical Conditions: National Medical Expenditure Survey.” Journal of Economic and Social Measurement, 19, 199-223.

Lau, D.T., Sosa, P., Dasgupta, N., & He, H. (2021). Impact of the COVID-19 Pandemic on Public Health Surveillance and Survey Data Collections in the United States.American Journal of Public Health, 111 (12), pp. 2118-2121.

Rothbaum, J. & Bee, A. (2021, May 3). Coronavirus Infects Surveys, Too: Survey Nonresponse Bias and the Coronavirus Pandemic. U.S. Census Bureau.

Rothbaum, J. & Bee, A. (2022, September 13). How Has the Pandemic Continued to Affect Survey Response? Using Administrative Data to Evaluate Nonresponse in the 2022 Current Population Survey Annual Social and Economic Supplement. U.S. Census Bureau.

Zuvekas, S.H. & Kashihara, D. (2021). The Impacts of the COVID-19 Pandemic on the Medical Expenditure Panel Survey. American Journal of Public Health, 111 (12), pp. 2157-2166.

Return To Table Of Contents

D. Variable-Source Crosswalk

MEPS HC-231: 2021 MEDICAL CONDITIONS

UNIQUE IDENTIFIER VARIABLES

VARIABLE LABEL SOURCE 1
DUID Panel # + Encrypted DU Identifier Assigned In Sampling
PID Person Number Assigned In Sampling
DUPERSID Person ID (DUID + PID) Assigned In Sampling
CONDN Condition Number CAPI Derived
CONDIDX Condition ID CAPI Derived
PANEL Panel Number Constructed
CONDRN Condition Round Number CAPI Derived

Return To Table Of Contents

MEDICAL CONDITION VARIABLES

VARIABLE LABEL SOURCE 1
AGEDIAG Age When Diagnosed PE section
CRND1 Has Condition Information In Round 1 Constructed
CRND2 Has Condition Information In Round 2 Constructed
CRND3 Has Condition Information In Round 3 Constructed
CRND4 Has Condition Information In Round 4 Constructed
CRND5 Has Condition Information In Round 5 Constructed
CRND6 Has Condition Information In Round 6 Constructed
CRND7 Has Condition Information In Round 7 Constructed
CRND8 Has Condition Information In Round 8 Constructed
CRND9 Has Condition Information In Round 9 Constructed
INJURY Was Condition Due To Accident/Injury AH80
ACCDNWRK Did Accident Occur At Work AH90
ICD10CDX ICD-10-CM Code For Condition Edited HS40, ER30, OP60, MV70, HH80, PM120, PE Section (Edited)
CCSR1X Clinical Classification Refined Code 1 Edited HS40, ER30, OP60, MV70, HH80, PM120, PE section (Edited)
CCSR2X Clinical Classification Refined Code 2 Edited HS40, ER30, OP60, MV70, HH80, PM120, PE section (Edited)
CCSR3X Clinical Classification Refined Code 3 Edited HS40, ER30, OP60, MV70, HH80, PM120, PE section (Edited)

Return To Table Of Contents

UTILIZATION VARIABLES

VARIABLE LABEL SOURCE 1
HHCOND # Any Home Health Events Assoc. w/ Condition? Constructed
IPCOND # Any Inpatient Events Assoc. w/ Condition? Constructed
OPCOND # Any Outpatient Events Assoc. w/ Condition? Constructed
OBCOND # Any Office-Based Events Assoc w/ Condition? Constructed
ERCOND # Any ER Events Assoc. w/ Condition? Constructed
RXCOND # Any Prescribed Medicines Assoc. w/ Cond.? Constructed

Return To Table Of Contents

WEIGHTS AND VARIANCE ESTIMATION VARIABLES

VARIABLE LABEL SOURCE 1
PERWT21F Expenditure File Person Weight, 2021 Constructed
VARSTR Variance Estimation Stratum, 2021 Constructed
VARPSU Variance Estimation PSU, 2021 Constructed

1See the Household Component section under Survey Questionnaires on the MEPS home page for information on the MEPS HC questionnaire sections shown in the Source column (e.g., PE).

Return To Table Of Contents

Appendix 1 ICD10CDX and CCSR Condition Code Frequencies

Table 1 UNWEIGHTED AND WEIGHTED COUNT OF RECORDS FOR EACH VALUE OF ICD10CDX

ICD10CDX VALUE ICD10CDX LABEL UNWEIGHTED WEIGHTED BY perwt21f
-15 CANNOT BE COMPUTED 7537 82120479.15
A08 VIRAL AND OTHER SPECIFIED INTESTINAL INFECTIONS 89 1095817.67
A09 INFECTIOUS GASTROENTERITIS AND COLITIS, UNSPECIFIED 42 504042.34
A49 BACTERIAL INFECTION OF UNSPECIFIED SITE 106 1350364.55
B00 HERPESVIRAL [HERPES SIMPLEX] INFECTIONS 134 1395652.46
B02 ZOSTER [HERPES ZOSTER] 146 1368707.73
B07 VIRAL WARTS 99 1339106.17
B34 VIRAL INFECTION OF UNSPECIFIED SITE 86 1227954.76
B35 DERMATOPHYTOSIS 193 2023551.28
B37 CANDIDIASIS 117 1391194.83
B99 OTHER AND UNSPECIFIED INFECTIOUS DISEASES 47 469334.17
C18 MALIGNANT NEOPLASM OF COLON 80 728579.32
C34 MALIGNANT NEOPLASM OF BRONCHUS AND LUNG 95 913489.91
C43 MALIGNANT MELANOMA OF SKIN 159 1670148.65
C44 OTHER AND UNSPECIFIED MALIGNANT NEOPLASM OF SKIN 497 4965827.64
C50 MALIGNANT NEOPLASM OF BREAST 256 2226561.45
C61 MALIGNANT NEOPLASM OF PROSTATE 210 2134646.69
C73 MALIGNANT NEOPLASM OF THYROID GLAND 65 719299.61
C85 OTH AND UNSPECIFIED TYPES OF NON-HODGKIN LYMPHOMA 42 460143.76
C95 LEUKEMIA OF UNSPECIFIED CELL TYPE 67 597101.42
D04 CARCINOMA IN SITU OF SKIN 117 1249690.30
D22 MELANOCYTIC NEVI 92 1095152.07
D48 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSP SITES 60 822449.74
D49 NEOPLASMS OF UNSPECIFIED BEHAVIOR 180 1985023.62
D50 IRON DEFICIENCY ANEMIA 104 1022061.64
D64 OTHER ANEMIAS 178 1689988.74
E03 OTHER HYPOTHYROIDISM 1099 12068765.72
E04 OTHER NONTOXIC GOITER 127 1252425.60
E05 THYROTOXICOSIS [HYPERTHYROIDISM] 174 1891924.55
E06 THYROIDITIS 87 1091467.93
E07 OTHER DISORDERS OF THYROID 629 5852893.31
E11 TYPE 2 DIABETES MELLITUS 3025 27819255.92
E28 OVARIAN DYSFUNCTION 47 762111.80
E29 TESTICULAR DYSFUNCTION 52 568071.38
E34 OTHER ENDOCRINE DISORDERS 110 1272144.99
E53 DEFICIENCY OF OTHER B GROUP VITAMINS 103 1095753.47
E55 VITAMIN D DEFICIENCY 458 4819430.24
E58 DIETARY CALCIUM DEFICIENCY 56 513223.23
E61 DEFICIENCY OF OTHER NUTRIENT ELEMENTS 181 1680059.10
E66 OVERWEIGHT AND OBESITY 167 1758565.50
E78 DISORDERS OF LIPOPROTEIN METABOLISM AND OTHER LIPIDEMIAS 5010 48579855.91
E86 VOLUME DEPLETION 83 748657.59
E87 OTHER DISORDERS OF FLUID, ELECTROLYTE AND ACID-BASE BALANCE 387 3217922.47
F03 UNSPECIFIED DEMENTIA 109 970174.81
F10 ALCOHOL RELATED DISORDERS 49 595371.61
F19 OTHER PSYCHOACTIVE SUBSTANCE RELATED DISORDERS 44 465718.57
F20 SCHIZOPHRENIA 82 680727.38
F31 BIPOLAR DISORDER 310 2848383.61
F32 MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE 2175 23268343.85
F34 PERSISTENT MOOD [AFFECTIVE] DISORDERS 61 649514.63
F39 UNSPECIFIED MOOD [AFFECTIVE] DISORDER 69 665355.70
F41 OTHER ANXIETY DISORDERS 2547 28918769.46
F42 OBSESSIVE-COMPULSIVE DISORDER 57 751547.48
F43 REACTION TO SEVERE STRESS, AND ADJUSTMENT DISORDERS 542 5834748.31
F80 SPECIFIC DEVELOPMENTAL DISORDERS OF SPEECH AND LANGUAGE 63 802184.54
F84 PERVASIVE DEVELOPMENTAL DISORDERS 112 1344415.99
F90 ATTENTION-DEFICIT HYPERACTIVITY DISORDERS 744 9744563.95
F91 CONDUCT DISORDERS 43 496735.14
F99 MENTAL DISORDER, NOT OTHERWISE SPECIFIED 259 2741775.75
G20 PARKINSON’S DISEASE 70 779692.26
G25 OTHER EXTRAPYRAMIDAL AND MOVEMENT DISORDERS 178 1627590.90
G30 ALZHEIMER’S DISEASE 59 520373.54
G35 MULTIPLE SCLEROSIS 71 829176.76
G40 EPILEPSY AND RECURRENT SEIZURES 140 1715215.85
G43 MIGRAINE 556 6368181.38
G45 TRANSIENT CEREBRAL ISCHEMIC ATTACKS AND RELATED SYNDROMES 350 3037137.78
G47 SLEEP DISORDERS 1550 15214610.93
G56 MONONEUROPATHIES OF UPPER LIMB 136 1530217.39
G57 MONONEUROPATHIES OF LOWER LIMB 126 1197632.07
G58 OTHER MONONEUROPATHIES 70 678459.10
G62 OTHER AND UNSPECIFIED POLYNEUROPATHIES 344 3123390.75
G89 PAIN, NOT ELSEWHERE CLASSIFIED 392 3691649.98
H04 DISORDERS OF LACRIMAL SYSTEM 309 2913606.62
H10 CONJUNCTIVITIS 61 851151.08
H26 OTHER CATARACT 764 6634104.39
H33 RETINAL DETACHMENTS AND BREAKS 84 829812.06
H35 OTHER RETINAL DISORDERS 325 2983271.78
H40 GLAUCOMA 555 5013149.20
H43 DISORDERS OF VITREOUS BODY 53 496586.38
H44 DISORDERS OF GLOBE 100 1032961.66
H52 DISORDERS OF REFRACTION AND ACCOMMODATION 418 5219342.11
H53 VISUAL DISTURBANCES 129 1288298.60
H54 BLINDNESS AND LOW VISION 167 1746782.41
H57 OTHER DISORDERS OF EYE AND ADNEXA 250 2481520.58
H61 OTHER DISORDERS OF EXTERNAL EAR 135 1483003.04
H66 SUPPURATIVE AND UNSPECIFIED OTITIS MEDIA 379 4942547.98
H91 OTHER AND UNSPECIFIED HEARING LOSS 324 3363277.00
H92 OTALGIA AND EFFUSION OF EAR 66 878513.67
H93 OTHER DISORDERS OF EAR, NOT ELSEWHERE CLASSIFIED 97 1101606.85
I10 ESSENTIAL (PRIMARY) HYPERTENSION 6593 62946340.94
I20 ANGINA PECTORIS 163 1678109.84
I21 ACUTE MYOCARDIAL INFARCTION 511 4769298.65
I25 CHRONIC ISCHEMIC HEART DISEASE 858 7871245.97
I26 PULMONARY EMBOLISM 68 700268.15
I34 NONRHEUMATIC MITRAL VALVE DISORDERS 53 597308.80
I38 ENDOCARDITIS, VALVE UNSPECIFIED 121 1243622.07
I48 ATRIAL FIBRILLATION AND FLUTTER 456 4492409.88
I49 OTHER CARDIAC ARRHYTHMIAS 353 3334327.96
I50 HEART FAILURE 208 1745406.48
I51 COMPLICATIONS AND ILL-DEFINED DESCRIPTIONS OF HEART DISEASE 274 2442546.72
I63 CEREBRAL INFARCTION 61 446907.01
I73 OTHER PERIPHERAL VASCULAR DISEASES 55 547698.26
I74 ARTERIAL EMBOLISM AND THROMBOSIS 356 3261653.40
I83 VARICOSE VEINS OF LOWER EXTREMITIES 50 669244.18
I87 OTHER DISORDERS OF VEINS 41 429358.25
I95 HYPOTENSION 77 822389.89
I99 OTHER AND UNSPECIFIED DISORDERS OF CIRCULATORY SYSTEM 92 717184.50
J00 ACUTE NASOPHARYNGITIS [COMMON COLD] 265 3262368.55
J02 ACUTE PHARYNGITIS 307 4100371.38
J06 ACUTE UPPER RESP INFECTIONS OF MULTIPLE AND UNSP SITES 101 1249254.55
J11 INFLUENZA DUE TO UNIDENTIFIED INFLUENZA VIRUS 158 1691895.02
J18 PNEUMONIA, UNSPECIFIED ORGANISM 279 2843204.02
J20 ACUTE BRONCHITIS 46 509665.71
J30 VASOMOTOR AND ALLERGIC RHINITIS 989 10874173.45
J32 CHRONIC SINUSITIS 518 6808221.11
J34 OTHER AND UNSPECIFIED DISORDERS OF NOSE AND NASAL SINUSES 174 1738081.13
J39 OTHER DISEASES OF UPPER RESPIRATORY TRACT 80 887660.30
J40 BRONCHITIS, NOT SPECIFIED AS ACUTE OR CHRONIC 173 1869410.08
J42 UNSPECIFIED CHRONIC BRONCHITIS 147 1094523.70
J43 EMPHYSEMA 162 1230571.30
J44 OTHER CHRONIC OBSTRUCTIVE PULMONARY DISEASE 389 3151056.50
J45 ASTHMA 1824 18827277.46
J98 OTHER RESPIRATORY DISORDERS 207 2449636.59
K04 DISEASES OF PULP AND PERIAPICAL TISSUES 158 1682305.02
K08 OTHER DISORDERS OF TEETH AND SUPPORTING STRUCTURES 287 3258788.65
K13 OTHER DISEASES OF LIP AND ORAL MUCOSA 56 561381.61
K21 GASTRO-ESOPHAGEAL REFLUX DISEASE 1791 17582843.36
K22 OTHER DISEASES OF ESOPHAGUS 75 800711.66
K25 GASTRIC ULCER 70 581823.17
K29 GASTRITIS AND DUODENITIS 137 982639.64
K30 FUNCTIONAL DYSPEPSIA 229 2257958.25
K31 OTHER DISEASES OF STOMACH AND DUODENUM 157 1383889.17
K44 DIAPHRAGMATIC HERNIA 72 699733.01
K46 UNSPECIFIED ABDOMINAL HERNIA 158 1585789.27
K50 CROHN’S DISEASE [REGIONAL ENTERITIS] 57 718287.99
K52 OTHER AND UNSP NONINFECTIVE GASTROENTERITIS AND COLITIS 59 475886.99
K57 DIVERTICULAR DISEASE OF INTESTINE 100 895385.63
K58 IRRITABLE BOWEL SYNDROME 118 1135443.95
K59 OTHER FUNCTIONAL INTESTINAL DISORDERS 324 3160806.68
K63 OTHER DISEASES OF INTESTINE 209 2105001.53
K64 HEMORRHOIDS AND PERIANAL VENOUS THROMBOSIS 85 835691.73
K76 OTHER DISEASES OF LIVER 121 1149295.87
K80 CHOLELITHIASIS 56 517791.25
K82 OTHER DISEASES OF GALLBLADDER 92 925490.19
K92 OTHER DISEASES OF DIGESTIVE SYSTEM 156 1511371.70
L02 CUTANEOUS ABSCESS, FURUNCLE AND CARBUNCLE 64 683797.73
L03 CELLULITIS AND ACUTE LYMPHANGITIS 92 1009307.47
L08 OTHER LOCAL INFECTIONS OF SKIN AND SUBCUTANEOUS TISSUE 203 2222606.37
L23 ALLERGIC CONTACT DERMATITIS 124 1441216.74
L29 PRURITUS 70 745722.11
L30 OTHER AND UNSPECIFIED DERMATITIS 278 3712889.32
L40 PSORIASIS 135 1526470.16
L60 NAIL DISORDERS 236 2348119.45
L65 OTHER NONSCARRING HAIR LOSS 61 661654.94
L70 ACNE 276 4154816.83
L71 ROSACEA 95 1089456.46
L72 FOLLICULAR CYSTS OF SKIN AND SUBCUTANEOUS TISSUE 118 1385996.86
L81 OTHER DISORDERS OF PIGMENTATION 46 626358.70
L84 CORNS AND CALLOSITIES 61 558858.18
L91 HYPERTROPHIC DISORDERS OF SKIN 55 676094.51
L98 OTH DISORDERS OF SKIN, SUBCU, NOT ELSEWHERE CLASSIFIED 452 5044722.48
M06 OTHER RHEUMATOID ARTHRITIS 486 4049192.94
M10 GOUT 386 3902358.47
M17 OSTEOARTHRITIS OF KNEE 156 1459867.21
M19 OTHER AND UNSPECIFIED OSTEOARTHRITIS 1811 16151291.76
M21 OTHER ACQUIRED DEFORMITIES OF LIMBS 85 921989.38
M25 OTHER JOINT DISORDER, NOT ELSEWHERE CLASSIFIED 1886 19060300.18
M32 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 80 764443.28
M35 OTHER SYSTEMIC INVOLVEMENT OF CONNECTIVE TISSUE 66 689645.80
M41 SCOLIOSIS 121 1401465.77
M43 OTHER DEFORMING DORSOPATHIES 51 523137.53
M48 OTHER SPONDYLOPATHIES 126 1202520.23
M50 CERVICAL DISC DISORDERS 60 592988.79
M51 THORACIC, THORACOLUM, AND LUMBOSACRAL INTVRT DISC DISORDERS 409 4210966.50
M53 OTHER AND UNSPECIFIED DORSOPATHIES, NOT ELSEWHERE CLASSIFIED 245 2450238.66
M54 DORSALGIA 1836 19101011.35
M62 OTHER DISORDERS OF MUSCLE 313 3198975.40
M65 SYNOVITIS AND TENOSYNOVITIS 81 794088.64
M71 OTHER BURSOPATHIES 55 620072.11
M72 FIBROBLASTIC DISORDERS 104 1153597.37
M75 SHOULDER LESIONS 203 2070882.64
M77 OTHER ENTHESOPATHIES 155 1663236.17
M79 OTH AND UNSP SOFT TISSUE DISORDERS, NOT ELSEWHERE CLASSIFIED 1141 11051403.52
M81 OSTEOPOROSIS WITHOUT CURRENT PATHOLOGICAL FRACTURE 274 2483407.86
M85 OTHER DISORDERS OF BONE DENSITY AND STRUCTURE 248 2353303.51
M89 OTHER DISORDERS OF BONE 70 509599.67
N15 OTHER RENAL TUBULO-INTERSTITIAL DISEASES 49 507852.21
N18 CHRONIC KIDNEY DISEASE (CKD) 66 639699.72
N19 UNSPECIFIED KIDNEY FAILURE 93 742830.54
N20 CALCULUS OF KIDNEY AND URETER 224 2459467.27
N28 OTH DISORDERS OF KIDNEY AND URETER, NOT ELSEWHERE CLASSIFIED 341 2912870.50
N30 CYSTITIS 106 927423.02
N32 OTHER DISORDERS OF BLADDER 203 2071200.69
N39 OTHER DISORDERS OF URINARY SYSTEM 779 8019554.24
N40 BENIGN PROSTATIC HYPERPLASIA 394 3953015.47
N42 OTHER AND UNSPECIFIED DISORDERS OF PROSTATE 183 1797378.62
N52 MALE ERECTILE DYSFUNCTION 110 1387973.15
N60 BENIGN MAMMARY DYSPLASIA 45 474015.18
N63 UNSPECIFIED LUMP IN BREAST 76 778362.45
N64 OTHER DISORDERS OF BREAST 50 594068.57
N76 OTHER INFLAMMATION OF VAGINA AND VULVA 42 492605.55
N81 FEMALE GENITAL PROLAPSE 46 430268.08
N83 NONINFLAMMATORY DISORD OF OVARY, FALLOP AND BROAD LIGAMENT 64 815388.28
N89 OTHER NONINFLAMMATORY DISORDERS OF VAGINA 57 609149.17
N92 EXCESSIVE, FREQUENT AND IRREGULAR MENSTRUATION 117 1590896.34
N94 PAIN AND OTH COND ASSOC W FEM GNTL ORG AND MENSTRUAL CYCLE 57 846175.75
N95 MENOPAUSAL AND OTHER PERIMENOPAUSAL DISORDERS 183 2062187.86
R00 ABNORMALITIES OF HEART BEAT 246 2587015.92
R01 CARDIAC MURMURS AND OTHER CARDIAC SOUNDS 127 1296350.93
R03 ABNORMAL BLOOD-PRESSURE READING, WITHOUT DIAGNOSIS 60 592844.86
R05 COUGH 258 2901065.40
R06 ABNORMALITIES OF BREATHING 305 2980856.39
R07 PAIN IN THROAT AND CHEST 212 2154975.68
R09 OTH SYMPTOMS AND SIGNS INVOLVING THE CIRC AND RESP SYS 155 1678606.11
R10 ABDOMINAL AND PELVIC PAIN 331 3450124.21
R11 NAUSEA AND VOMITING 314 3349551.08
R12 HEARTBURN 216 2158854.77
R19 OTH SYMPTOMS AND SIGNS INVOLVING THE DGSTV SYS AND ABDOMEN 119 1164697.46
R20 DISTURBANCES OF SKIN SENSATION 68 549336.70
R21 RASH AND OTHER NONSPECIFIC SKIN ERUPTION 340 3547349.53
R22 LOCALIZED SWELLING, MASS AND LUMP OF SKIN, SUBCU 104 1351030.86
R25 ABNORMAL INVOLUNTARY MOVEMENTS 143 1161474.31
R26 ABNORMALITIES OF GAIT AND MOBILITY 89 830061.49
R32 UNSPECIFIED URINARY INCONTINENCE 199 1826859.82
R35 POLYURIA 70 721162.52
R39 OTH AND UNSP SYMPTOMS AND SIGNS INVOLVING THE GU SYS 71 730519.35
R41 OTH SYMPTOMS AND SIGNS W COGNITIVE FUNCTIONS AND AWARENESS 166 1628994.13
R42 DIZZINESS AND GIDDINESS 327 3038004.99
R45 SYMPTOMS AND SIGNS INVOLVING EMOTIONAL STATE 44 422460.58
R47 SPEECH DISTURBANCES, NOT ELSEWHERE CLASSIFIED 65 676117.29
R50 FEVER OF OTHER AND UNKNOWN ORIGIN 126 1634257.43
R51 HEADACHE 202 2038393.95
R52 PAIN, UNSPECIFIED 232 1768336.39
R53 MALAISE AND FATIGUE 147 1451001.92
R54 AGE-RELATED PHYSICAL DEBILITY 120 1110548.85
R55 SYNCOPE AND COLLAPSE 53 508076.92
R56 CONVULSIONS, NOT ELSEWHERE CLASSIFIED 150 1361090.47
R60 EDEMA, NOT ELSEWHERE CLASSIFIED 563 4816508.44
R63 SYMPTOMS AND SIGNS CONCERNING FOOD AND FLUID INTAKE 95 824417.24
R73 ELEVATED BLOOD GLUCOSE LEVEL 303 3104224.26
R87 ABNORMAL FINDINGS IN SPECIMENS FROM FEMALE GENITAL ORGANS 55 575094.39
R91 ABNORMAL FINDINGS ON DIAGNOSTIC IMAGING OF LUNG 63 697927.55
R97 ABNORMAL TUMOR MARKERS 45 443694.63
S01 OPEN WOUND OF HEAD 45 498244.60
S06 INTRACRANIAL INJURY 73 813238.36
S09 OTHER AND UNSPECIFIED INJURIES OF HEAD 72 796023.26
S22 FRACTURE OF RIB(S), STERNUM AND THORACIC SPINE 41 438390.09
S32 FRACTURE OF LUMBAR SPINE AND PELVIS 62 498869.36
S39 OTH & UNSP INJURIES OF ABD, LOW BACK, PELV & EXTRN GENITALS 233 2751684.96
S42 FRACTURE OF SHOULDER AND UPPER ARM 99 1082279.38
S46 INJURY OF MUSCLE, FASCIA AND TENDON AT SHLDR/UP ARM 88 929845.11
S49 OTHER AND UNSPECIFIED INJURIES OF SHOULDER AND UPPER ARM 136 1317154.54
S61 OPEN WOUND OF WRIST, HAND AND FINGERS 83 1023166.06
S62 FRACTURE AT WRIST AND HAND LEVEL 129 1477685.63
S63 DISLOCATION AND SPRAIN OF JOINTS AND LIGAMENTS AT WRS/HND LV 42 448508.48
S69 OTHER AND UNSPECIFIED INJURIES OF WRIST, HAND AND FINGER(S) 102 1381664.31
S72 FRACTURE OF FEMUR 42 490558.41
S82 FRACTURE OF LOWER LEG, INCLUDING ANKLE 128 1694149.71
S83 DISLOCATION AND SPRAIN OF JOINTS AND LIGAMENTS OF KNEE 119 1210701.71
S89 OTHER AND UNSPECIFIED INJURIES OF LOWER LEG 142 1484705.99
S92 FRACTURE OF FOOT AND TOE, EXCEPT ANKLE 101 1039620.60
S93 DISLOC & SPRAIN OF JOINTS & LIGAMENTS AT ANKL, FT & TOE LEV 116 1306585.95
S99 OTHER AND UNSPECIFIED INJURIES OF ANKLE AND FOOT 100 1341590.74
T14 INJURY OF UNSPECIFIED BODY REGION 377 4225668.96
T63 TOXIC EFFECT OF CONTACT WITH VENOMOUS ANIMALS AND PLANTS 102 1122084.62
T78 ADVERSE EFFECTS, NOT ELSEWHERE CLASSIFIED 656 6276512.11
T88 OTH COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NEC 69 661363.68
U07 EMERGENCY USE OF U07 1695 21056866.35
Z00 ENCNTR FOR GENERAL EXAM W/O COMPLAINT, SUSP OR REPRTD DX 309 3764860.70
Z01 ENCNTR FOR OTH SP EXAM W/O COMPLAINT, SUSPECTED OR REPRTD DX 256 2538813.38
Z04 ENCOUNTER FOR EXAMINATION AND OBSERVATION FOR OTHER REASONS 93 915741.28
Z12 ENCOUNTER FOR SCREENING FOR MALIGNANT NEOPLASMS 322 3324155.37
Z13 ENCOUNTER FOR SCREENING FOR OTHER DISEASES AND DISORDERS 400 3231442.18
Z20 CONTACT W AND (SUSPECTED) EXPOSURE TO COMMUNICABLE DISEASES 2117 28244441.99
Z21 ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS INFECTION STATUS 75 619663.70
Z23 ENCOUNTER FOR IMMUNIZATION 2448 29080545.70
Z29 ENCOUNTER FOR OTHER PROPHYLACTIC MEASURES 132 1409829.49
Z30 ENCOUNTER FOR CONTRACEPTIVE MANAGEMENT 450 6574003.91
Z34 ENCOUNTER FOR SUPERVISION OF NORMAL PREGNANCY 312 3962987.98
Z38 LIVEBORN INFANTS ACCORDING TO PLACE OF BIRTH AND TYPE OF DEL 53 870585.24
Z45 ENCOUNTER FOR ADJUSTMENT AND MANAGEMENT OF IMPLANTED DEVICE 48 440046.06
Z51 ENCOUNTER FOR OTHER AFTERCARE AND MEDICAL CARE 66 590198.28
Z63 OTH PROB REL TO PRIM SUPPORT GROUP, INC FAMILY CIRCUMSTANCES 63 724066.89
Z71 PERSONS ENCNTR HEALTH SERV FOR OTH CNSL AND MED ADVICE, NEC 253 2930457.17
Z76 PERSONS ENCOUNTERING HEALTH SERVICES IN OTHER CIRCUMSTANCES 244 2307686.06
Z79 LONG TERM (CURRENT) DRUG THERAPY 409 3966341.57
Z90 ACQUIRED ABSENCE OF ORGANS, NOT ELSEWHERE CLASSIFIED 50 559867.94
Z91 PERSONAL RISK FACTORS, NOT ELSEWHERE CLASSIFIED 82 1048130.70
Z95 PRESENCE OF CARDIAC AND VASCULAR IMPLANTS AND GRAFTS 103 992734.93
Z96 PRESENCE OF OTHER FUNCTIONAL IMPLANTS 243 2350559.92
Z97 PRESENCE OF OTHER DEVICES 86 813666.87
94641 984161434.18

Return To Table Of Contents

Table 2 UNWEIGHTED AND WEIGHTED COUNT OF RECORDS FOR EACH VALUE OF CCSR COMBINATION

CCSR1X VALUE CCSR1X LABEL CCSR2X VALUE CCSR2X LABEL CCSR3X VALUE CCSR3X LABEL UNWEIGHTED WEIGHTED BY perwt21f
-15 CANNOT BE COMPUTED -1 INAPPLICABLE -1 INAPPLICABLE 472 4498471.22
BLD000 DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS -1 INAPPLICABLE -1 INAPPLICABLE 147 1455608.31
BLD000 DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS CIR000 DISEASES OF THE CIRCULATORY SYSTEM -1 INAPPLICABLE 1 10889.00
BLD000 DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE 1 26110.31
BLD000 DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS NEO000 NEOPLASMS -1 INAPPLICABLE 4 59926.20
BLD001 NUTRITIONAL ANEMIA -1 INAPPLICABLE -1 INAPPLICABLE 104 1022061.64
BLD003 APLASTIC ANEMIA -1 INAPPLICABLE -1 INAPPLICABLE 178 1689988.74
BLD008 IMMUNITY DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 42 452854.04
CIR000 DISEASES OF THE CIRCULATORY SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 363 3506496.18
CIR000 DISEASES OF THE CIRCULATORY SYSTEM FAC000 FACTORS INFLUENCING HEALTH STATUS & CONTACT W/ HEALTH SER -1 INAPPLICABLE 21 202401.06
CIR000 DISEASES OF THE CIRCULATORY SYSTEM GEN000 DISEASES OF THE GENITOURINARY SYSTEM -1 INAPPLICABLE 1 4760.58
CIR000 DISEASES OF THE CIRCULATORY SYSTEM MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE 5 56077.45
CIR003 NONRHEUMATIC AND UNSPECIFIED VALVE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 53 597308.80
CIR004 ENDOCARDITIS AND ENDOCARDIAL DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 121 1243622.07
CIR007 ESSENTIAL HYPERTENSION -1 INAPPLICABLE -1 INAPPLICABLE 6593 62946340.94
CIR009 ACUTE MYOCARDIAL INFARCTION -1 INAPPLICABLE -1 INAPPLICABLE 511 4769298.65
CIR011 CORONARY ATHEROSCLEROSIS AND OTHER HEART DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 1021 9549355.81
CIR011 CORONARY ATHEROSCLEROSIS AND OTHER HEART DISEASE FAC009 IMPLANT, DEVICE OR GRAFT RELATED ENCOUNTER -1 INAPPLICABLE 59 587356.65
CIR012 NONSPECIFIC CHEST PAIN -1 INAPPLICABLE -1 INAPPLICABLE 212 2154975.68
CIR013 ACUTE PULMONARY EMBOLISM -1 INAPPLICABLE -1 INAPPLICABLE 68 700268.15
CIR015 OTHER AND ILL-DEFINED HEART DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 274 2442546.72
CIR016 CONDUCTION DISORDERS FAC009 IMPLANT, DEVICE OR GRAFT RELATED ENCOUNTER -1 INAPPLICABLE 92 845424.34
CIR017 CARDIAC DYSRHYTHMIAS -1 INAPPLICABLE -1 INAPPLICABLE 809 7826737.84
CIR019 HEART FAILURE -1 INAPPLICABLE -1 INAPPLICABLE 208 1745406.48
CIR020 CEREBRAL INFARCTION -1 INAPPLICABLE -1 INAPPLICABLE 61 446907.01
CIR026 PERIPHERAL AND VISCERAL VASCULAR DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 55 547698.26
CIR029 AORTIC; PERIPHERAL; AND VISCERAL ARTERY ANEURYSMS -1 INAPPLICABLE -1 INAPPLICABLE 62 454611.01
CIR030 AORTIC AND PERIPHERAL ARTERIAL EMBOLISM OR THROMBOSIS -1 INAPPLICABLE -1 INAPPLICABLE 356 3261653.40
CIR031 HYPOTENSION -1 INAPPLICABLE -1 INAPPLICABLE 77 822389.89
CIR032 OTHER SPECIFIED AND UNSPECIFIED CIRCULATORY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 92 717184.50
CIR035 VARICOSE VEINS OF LOWER EXTREMITY -1 INAPPLICABLE -1 INAPPLICABLE 50 669244.18
CIR039 OTHER SPECIFIED DISEASES OF VEINS AND LYMPHATICS -1 INAPPLICABLE -1 INAPPLICABLE 41 429358.25
DIG000 DISEASES OF THE DIGESTIVE SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 325 3479865.42
DIG000 DISEASES OF THE DIGESTIVE SYSTEM INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE 70 868001.86
DIG000 DISEASES OF THE DIGESTIVE SYSTEM INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE 1 20233.25
DIG000 DISEASES OF THE DIGESTIVE SYSTEM MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE 3 41820.88
DIG000 DISEASES OF THE DIGESTIVE SYSTEM NEO000 NEOPLASMS -1 INAPPLICABLE 7 66506.46
DIG000 DISEASES OF THE DIGESTIVE SYSTEM SYM000 SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC -1 INAPPLICABLE 14 147497.74
DIG001 INTESTINAL INFECTION INF008 VIRAL INFECTION -1 INAPPLICABLE 89 1095817.67
DIG001 INTESTINAL INFECTION INF009 PARASITIC, OTHER SPECIFIED AND UNSPECIFIED INFECTIONS -1 INAPPLICABLE 42 504042.34
DIG002 DISORDERS OF TEETH AND GINGIVA -1 INAPPLICABLE -1 INAPPLICABLE 588 6699419.38
DIG003 DISEASES OF MOUTH; EXCLUDING DENTAL -1 INAPPLICABLE -1 INAPPLICABLE 56 561381.61
DIG004 ESOPHAGEAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 1866 18383555.02
DIG005 GASTRODUODENAL ULCER -1 INAPPLICABLE -1 INAPPLICABLE 70 581823.17
DIG007 GASTRITIS AND DUODENITIS -1 INAPPLICABLE -1 INAPPLICABLE 137 982639.64
DIG008 OTH SPECIFIED & UNSPECIFIED DISORDERS OF STOMACH & DUODEN -1 INAPPLICABLE -1 INAPPLICABLE 386 3641847.43
DIG010 ABDOMINAL HERNIA -1 INAPPLICABLE -1 INAPPLICABLE 230 2285522.28
DIG011 REGIONAL ENTERITIS AND ULCERATIVE COLITIS -1 INAPPLICABLE -1 INAPPLICABLE 57 718287.99
DIG013 DIVERTICULOSIS AND DIVERTICULITIS -1 INAPPLICABLE -1 INAPPLICABLE 100 895385.63
DIG014 HEMORRHOIDS -1 INAPPLICABLE -1 INAPPLICABLE 85 835691.73
DIG017 BILIARY TRACT DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 148 1443281.44
DIG019 OTHER SPECIFIED AND UNSPECIFIED LIVER DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 157 1544210.90
DIG021 GASTROINTESTINAL HEMORRHAGE -1 INAPPLICABLE -1 INAPPLICABLE 57 547900.58
DIG022 NONINFECTIOUS GASTROENTERITIS -1 INAPPLICABLE -1 INAPPLICABLE 59 475886.99
DIG025 OTHER SPECIFIED AND UNSPECIFIED GASTROINTESTINAL DISORDER -1 INAPPLICABLE -1 INAPPLICABLE 682 6546875.76
EAR000 DISEASES OF THE EAR AND MASTOID PROCESS -1 INAPPLICABLE -1 INAPPLICABLE 84 1095091.29
EAR000 DISEASES OF THE EAR AND MASTOID PROCESS INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE 1 17350.95
EAR001 OTITIS MEDIA -1 INAPPLICABLE -1 INAPPLICABLE 379 4942547.98
EAR004 HEARING LOSS -1 INAPPLICABLE -1 INAPPLICABLE 324 3363277.00
EAR006 OTHER SPECIFIED AND UNSPECIFIED DISORDERS OF THE EAR -1 INAPPLICABLE -1 INAPPLICABLE 298 3463123.57
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES -1 INAPPLICABLE -1 INAPPLICABLE 97 1056425.01
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES EYE000 DISEASES OF THE EYE AND ADNEXA -1 INAPPLICABLE 29 266808.70
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES GEN000 DISEASES OF THE GENITOURINARY SYSTEM -1 INAPPLICABLE 9 78279.47
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES NVS000 DISEASES OF THE NERVOUS SYSTEM -1 INAPPLICABLE 2 11227.87
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE 9 79194.44
END001 THYROID DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 2116 22157477.12
END002 DIABETES MELLITUS WITHOUT COMPLICATION END005 DIABETES MELLITUS, TYPE 2 -1 INAPPLICABLE 2957 27139537.15
END003 DIABETES MELLITUS WITH COMPLICATION END005 DIABETES MELLITUS, TYPE 2 NVS020 OTHER SPECIFIED NERVOUS SYSTEM DISORDERS 68 679718.77
END007 NUTRITIONAL DEFICIENCIES -1 INAPPLICABLE -1 INAPPLICABLE 840 8465250.27
END009 OBESITY -1 INAPPLICABLE -1 INAPPLICABLE 112 1225780.32
END010 DISORDERS OF LIPID METABOLISM -1 INAPPLICABLE -1 INAPPLICABLE 5010 48579855.91
END011 FLUID AND ELECTROLYTE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 470 3966580.06
END015 OTHER SPECIFIED AND UNSPECIFIED ENDOCRINE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 272 3263964.65
END016 OTH SPECIFIED & UNSPEC NUTRITIONAL AND METABOLIC DISORDER -1 INAPPLICABLE -1 INAPPLICABLE 145 1436804.12
EXT000 EXTERNAL CAUSES OF MORBIDITY INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE 1 5057.41
EYE000 DISEASES OF THE EYE AND ADNEXA -1 INAPPLICABLE -1 INAPPLICABLE 144 1739522.62
EYE000 DISEASES OF THE EYE AND ADNEXA INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE 2 13729.16
EYE001 CORNEA AND EXTERNAL DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 141 1773739.18
EYE002 CATARACT AND OTHER LENS DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 764 6634104.39
EYE003 GLAUCOMA -1 INAPPLICABLE -1 INAPPLICABLE 555 5013149.20
EYE004 UVEITIS AND OCULAR INFLAMMATION -1 INAPPLICABLE -1 INAPPLICABLE 100 1032961.66
EYE005 RETINAL AND VITREOUS CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE 462 4309670.22
EYE008 OCULOFACIAL PLASTICS AND ORBITAL CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE 347 3322219.03
EYE009 REFRACTIVE ERROR -1 INAPPLICABLE -1 INAPPLICABLE 418 5219342.11
EYE010 BLINDNESS AND VISION DEFECTS -1 INAPPLICABLE -1 INAPPLICABLE 296 3035081.01
EYE012 OTHER SPECIFIED EYE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 250 2481520.58
FAC000 FACTORS INFLUENCING HEALTH STATUS & CONTACT W/ HEALTH SER -1 INAPPLICABLE -1 INAPPLICABLE 373 4363428.12
FAC003 ENCTR FOR OBS, EXAM COND R/O, EXCL INFECT DIS, NPL, MENT -1 INAPPLICABLE -1 INAPPLICABLE 493 4147183.46
FAC005 ENCOUNTER FOR PROPHYLACTIC MEASURES (EXCLUDES IMMUNIZATIO -1 INAPPLICABLE -1 INAPPLICABLE 132 1409829.49
FAC008 NEOPLASM-RELATED ENCOUNTERS -1 INAPPLICABLE -1 INAPPLICABLE 322 3324155.37
FAC009 IMPLANT, DEVICE OR GRAFT RELATED ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 438 4283586.08
FAC010 OTHER AFTERCARE ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 144 1399178.52
FAC012 OTHER SPECIFIED ENCOUNTERS AND COUNSELING -1 INAPPLICABLE -1 INAPPLICABLE 497 5238143.23
FAC013 CONTRACEPTIVE AND PROCREATIVE MANAGEMENT -1 INAPPLICABLE -1 INAPPLICABLE 450 6574003.91
FAC014 MEDICAL EXAMINATION/EVALUATION -1 INAPPLICABLE -1 INAPPLICABLE 565 6303674.08
FAC016 EXPOSURE, ENCTR, SCREENING OR CONTACT W/ INFECTIOUS DISEA -1 INAPPLICABLE -1 INAPPLICABLE 4565 57324987.69
FAC019 SOCIOECONOMIC/PSYCHOSOCIAL FACTORS -1 INAPPLICABLE -1 INAPPLICABLE 63 724066.89
FAC022 ACQUIRED ABSENCE OF LIMB OR ORGAN -1 INAPPLICABLE -1 INAPPLICABLE 50 559867.94
FAC025 OTHER SPECIFIED STATUS -1 INAPPLICABLE -1 INAPPLICABLE 389 3879329.35
GEN000 DISEASES OF THE GENITOURINARY SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 205 2409373.22
GEN000 DISEASES OF THE GENITOURINARY SYSTEM INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE 5 106297.86
GEN000 DISEASES OF THE GENITOURINARY SYSTEM INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE 1 9526.52
GEN001 NEPHRITIS; NEPHROSIS; RENAL SCLEROSIS -1 INAPPLICABLE -1 INAPPLICABLE 49 507852.21
GEN002 ACUTE AND UNSPECIFIED RENAL FAILURE -1 INAPPLICABLE -1 INAPPLICABLE 93 742830.54
GEN003 CHRONIC KIDNEY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 66 639699.72
GEN004 URINARY TRACT INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE 807 8273877.67
GEN005 CALCULUS OF URINARY TRACT -1 INAPPLICABLE -1 INAPPLICABLE 224 2459467.27
GEN006 OTH SPECIFIED AND UNSPECIFIED DISEASES OF KIDNEY AND URET -1 INAPPLICABLE -1 INAPPLICABLE 341 2912870.50
GEN007 OTH SPECIFIED & UNSPECIFIED DISEASES OF BLADDER AND URETH -1 INAPPLICABLE -1 INAPPLICABLE 203 2071200.69
GEN008 URINARY INCONTINENCE -1 INAPPLICABLE -1 INAPPLICABLE 199 1826859.82
GEN012 HYPERPLASIA OF PROSTATE -1 INAPPLICABLE -1 INAPPLICABLE 394 3953015.47
GEN013 INFLAMMATORY CONDITIONS OF MALE GENITAL ORGANS -1 INAPPLICABLE -1 INAPPLICABLE 45 467662.13
GEN014 ERECTILE DYSFUNCTION -1 INAPPLICABLE -1 INAPPLICABLE 110 1387973.15
GEN016 OTHER SPECIFIED MALE GENITAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 220 2331115.62
GEN017 NONMALIGNANT BREAST CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE 171 1846446.20
GEN018 INFLAMMATORY DISEASES OF FEMALE PELVIC ORGANS -1 INAPPLICABLE -1 INAPPLICABLE 42 492605.55
GEN018 INFLAMMATORY DISEASES OF FEMALE PELVIC ORGANS GEN025 OTHER SPECIFIED FEMALE GENITAL DISORDERS INF004 FUNGAL INFECTIONS 67 831639.64
GEN019 ENDOMETRIOSIS -1 INAPPLICABLE -1 INAPPLICABLE 39 500030.33
GEN020 PROLAPSE OF FEMALE GENITAL ORGANS -1 INAPPLICABLE -1 INAPPLICABLE 46 430268.08
GEN021 MENSTRUAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 174 2437072.10
GEN022 BENIGN OVARIAN CYST -1 INAPPLICABLE -1 INAPPLICABLE 64 815388.28
GEN023 MENOPAUSAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 285 3197330.78
GEN025 OTHER SPECIFIED FEMALE GENITAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 150 1896726.58
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE -1 INAPPLICABLE 159 1652190.55
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE 10 79565.06
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES NVS000 DISEASES OF THE NERVOUS SYSTEM -1 INAPPLICABLE 4 37063.61
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES PNL000 CERTAIN CONDITIONS ORIGINATING IN THE PERINATAL PERIOD -1 INAPPLICABLE 4 70603.18
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES RSP000 DISEASES OF THE RESPIRATORY SYSTEM -1 INAPPLICABLE 5 30185.16
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE 7 70110.29
INF003 BACTERIAL INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE 106 1350364.55
INF003 BACTERIAL INFECTIONS RSP006 OTHER SPECIFIED UPPER RESPIRATORY INFECTIONS -1 INAPPLICABLE 164 2390277.82
INF004 FUNGAL INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE 321 3367996.49
INF006 HIV INFECTION -1 INAPPLICABLE -1 INAPPLICABLE 75 619663.70
INF008 VIRAL INFECTION -1 INAPPLICABLE -1 INAPPLICABLE 378 4383148.08
INF008 VIRAL INFECTION SKN007 OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS -1 INAPPLICABLE 87 948273.04
INF009 PARASITIC, OTHER SPECIFIED AND UNSPECIFIED INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE 99 1038852.18
INF012 CORONAVIRUS DISEASE - 2019 (COVID-19) -1 INAPPLICABLE -1 INAPPLICABLE 1695 21056866.35
INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE -1 INAPPLICABLE 288 3132518.36
INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU MBD000 MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS -1 INAPPLICABLE 2 14544.33
INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU NVS000 DISEASES OF THE NERVOUS SYSTEM -1 INAPPLICABLE 3 34819.80
INJ027 OTHER UNSPECIFIED INJURY -1 INAPPLICABLE -1 INAPPLICABLE 91 1038462.78
INJ031 ALLERGIC REACTIONS RSP007 OTHER SPECIFIED AND UNSPECIFIED UPPER RESPIRATORY DISEASE -1 INAPPLICABLE 989 10874173.45
INJ031 ALLERGIC REACTIONS SKN002 OTHER SPECIFIED INFLAMMATORY CONDITION OF SKIN -1 INAPPLICABLE 51 608729.21
INJ031 ALLERGIC REACTIONS SKN005 CONTACT DERMATITIS -1 INAPPLICABLE 124 1441216.74
INJ031 ALLERGIC REACTIONS SKN007 OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS -1 INAPPLICABLE 278 3712889.32
INJ039 FRACTURE OF THE SPINE AND BACK, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 62 498869.36
INJ040 FRACTURE OF TORSO, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 41 438390.09
INJ041 FRACTURE OF THE UPPER LIMB, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 228 2559965.01
INJ042 FRACTURE OF LOWER LIMB (EXCEPT HIP), SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 229 2733770.30
INJ043 FRACTURE OF THE NECK OF THE FEMUR (HIP), SUBSEQUENT ENCTR -1 INAPPLICABLE -1 INAPPLICABLE 42 490558.41
INJ044 DISLOCATIONS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 44 418046.97
INJ045 TRAUMATIC BRAIN INJURY (TBI); CONCUSSION, SUBSEQUENT ENCT -1 INAPPLICABLE -1 INAPPLICABLE 73 813238.36
INJ048 OPEN WOUNDS OF HEAD AND NECK, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 45 498244.60
INJ049 OPEN WOUNDS TO LIMBS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 123 1376222.91
INJ054 SUPERFICIAL INJURY; CONTUSION, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 73 897572.46
INJ060 TOXIC EFFECTS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 102 1122084.62
INJ061 SPRAINS AND STRAINS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 685 7847571.91
INJ064 OTHER UNSPECIFIED INJURIES, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 1073 11980897.27
INJ067 ALLERGIC REACTIONS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 656 6276512.11
INJ072 COMPLC OF OTHER SURGICAL/MEDICAL CARE, INJURY, SUBSEQ ENC -1 INAPPLICABLE -1 INAPPLICABLE 69 661363.68
MAL000 CONGENITAL MALFORMATIONS, DEFORMATIONS & CHROMOSOMAL ABNO -1 INAPPLICABLE -1 INAPPLICABLE 95 1500574.92
MBD000 MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 224 2470150.27
MBD000 MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS PRG000 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM -1 INAPPLICABLE 2 33681.27
MBD001 SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 82 680727.38
MBD002 DEPRESSIVE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 2175 23268343.85
MBD003 BIPOLAR AND RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 310 2848383.61
MBD004 OTHER SPECIFIED AND UNSPECIFIED MOOD DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 130 1314870.33
MBD005 ANXIETY AND FEAR-RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 2547 28918769.46
MBD006 OBSESSIVE-COMPULSIVE AND RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 57 751547.48
MBD007 TRAUMA- AND STRESSOR-RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 542 5834748.31
MBD008 DISRUPTIVE, IMPULSE-CONTROL AND CONDUCT DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 43 496735.14
MBD013 MISCELLANEOUS MENTAL AND BEHAVIORAL DISORDERS/CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE 295 3201716.90
MBD014 NEURODEVELOPMENTAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 967 12441252.27
MBD017 ALCOHOL-RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 49 595371.61
MBD025 OTHER SPECIFIED SUBSTANCE-RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 44 465718.57
MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE -1 INAPPLICABLE 227 2590080.43
MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE 32 439353.47
MUS003 RHEUMATOID ARTHRITIS AND RELATED DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 486 4049192.94
MUS006 OSTEOARTHRITIS -1 INAPPLICABLE -1 INAPPLICABLE 2000 17893589.27
MUS007 OTHER SPECIFIED JOINT DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 392 3685740.94
MUS009 TENDON AND SYNOVIAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 389 3906225.12
MUS010 MUSCULOSKELETAL PAIN, NOT LOW BACK PAIN -1 INAPPLICABLE -1 INAPPLICABLE 2973 30465376.76
MUS011 SPONDYLOPATHIES/SPONDYLOARTHROPATHY (INCLUDING INFECTIVE) -1 INAPPLICABLE -1 INAPPLICABLE 946 9516582.29
MUS011 SPONDYLOPATHIES/SPONDYLOARTHROPATHY (INCLUDING INFECTIVE) MUS038 LOW BACK PAIN -1 INAPPLICABLE 644 6680905.01
MUS013 OSTEOPOROSIS -1 INAPPLICABLE -1 INAPPLICABLE 274 2483407.86
MUS021 ACQUIRED FOOT DEFORMITIES -1 INAPPLICABLE -1 INAPPLICABLE 85 921989.38
MUS022 SCOLIOSIS AND OTHER POSTURAL DORSOPATHIC DEFORMITIES -1 INAPPLICABLE -1 INAPPLICABLE 121 1401465.77
MUS024 SYSTEMIC LUPUS ERYTHEMATOSUS AND CONNECTIVE TISSUE DISORD -1 INAPPLICABLE -1 INAPPLICABLE 146 1454089.08
MUS025 OTHER SPECIFIED CONNECTIVE TISSUE DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 897 9082515.42
MUS026 MUSCLE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 222 2137930.97
MUS028 OTHER SPECIFIED BONE DISEASE AND MUSCULOSKELETAL DEFORMIT -1 INAPPLICABLE -1 INAPPLICABLE 318 2862903.18
MUS033 GOUT -1 INAPPLICABLE -1 INAPPLICABLE 386 3902358.47
MUS038 LOW BACK PAIN -1 INAPPLICABLE -1 INAPPLICABLE 401 4329366.71
NEO000 NEOPLASMS -1 INAPPLICABLE -1 INAPPLICABLE 345 3459323.76
NEO000 NEOPLASMS NVS000 DISEASES OF THE NERVOUS SYSTEM -1 INAPPLICABLE 4 28515.03
NEO015 GASTROINTESTINAL CANCERS - COLORECTAL -1 INAPPLICABLE -1 INAPPLICABLE 80 728579.32
NEO022 RESPIRATORY CANCERS -1 INAPPLICABLE -1 INAPPLICABLE 95 913489.91
NEO025 SKIN CANCERS - MELANOMA -1 INAPPLICABLE -1 INAPPLICABLE 159 1670148.65
NEO026 SKIN CANCERS - BASAL CELL CARCINOMA -1 INAPPLICABLE -1 INAPPLICABLE 88 963909.38
NEO027 SKIN CANCERS - SQUAMOUS CELL CARCINOMA -1 INAPPLICABLE -1 INAPPLICABLE 77 826348.00
NEO028 SKIN CANCERS - ALL OTHER TYPES -1 INAPPLICABLE -1 INAPPLICABLE 449 4425260.56
NEO030 BREAST CANCER - ALL OTHER TYPES -1 INAPPLICABLE -1 INAPPLICABLE 256 2226561.45
NEO039 MALE REPRODUCTIVE SYSTEM CANCERS - PROSTATE -1 INAPPLICABLE -1 INAPPLICABLE 210 2134646.69
NEO043 URINARY SYSTEM CANCERS - BLADDER -1 INAPPLICABLE -1 INAPPLICABLE 39 378755.95
NEO050 ENDOCRINE SYSTEM CANCERS - THYROID -1 INAPPLICABLE -1 INAPPLICABLE 65 719299.61
NEO058 NON-HODGKIN LYMPHOMA -1 INAPPLICABLE -1 INAPPLICABLE 42 460143.76
NEO064 LEUKEMIA - ALL OTHER TYPES -1 INAPPLICABLE -1 INAPPLICABLE 67 597101.42
NEO072 NEOPLASMS OF UNSPECIFIED NATURE OR UNCERTAIN BEHAVIOR -1 INAPPLICABLE -1 INAPPLICABLE 240 2807473.36
NEO073 BENIGN NEOPLASMS -1 INAPPLICABLE -1 INAPPLICABLE 364 4062962.85
NVS000 DISEASES OF THE NERVOUS SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 136 1446670.52
NVS000 DISEASES OF THE NERVOUS SYSTEM SYM000 SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC -1 INAPPLICABLE 1 8937.27
NVS004 PARKINSON`S DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 70 779692.26
NVS005 MULTIPLE SCLEROSIS -1 INAPPLICABLE -1 INAPPLICABLE 71 829176.76
NVS006 OTH SPECIFIED HEREDITARY & DEGENERATIVE NERVOUS SYSTEM CO -1 INAPPLICABLE -1 INAPPLICABLE 49 549905.84
NVS006 OTH SPECIFIED HEREDITARY & DEGENERATIVE NERVOUS SYSTEM CO NVS016 SLEEP WAKE DISORDERS -1 INAPPLICABLE 178 1627590.90
NVS009 EPILEPSY; CONVULSIONS -1 INAPPLICABLE -1 INAPPLICABLE 290 3076306.31
NVS010 HEADACHE; INCLUDING MIGRAINE -1 INAPPLICABLE -1 INAPPLICABLE 582 6648344.80
NVS010 HEADACHE; INCLUDING MIGRAINE SYM010 NERVOUS SYSTEM SIGNS AND SYMPTOMS -1 INAPPLICABLE 202 2038393.95
NVS011 NEUROCOGNITIVE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 168 1490548.35
NVS012 TRANSIENT CEREBRAL ISCHEMIA -1 INAPPLICABLE -1 INAPPLICABLE 350 3037137.78
NVS015 POLYNEUROPATHIES -1 INAPPLICABLE -1 INAPPLICABLE 344 3123390.75
NVS016 SLEEP WAKE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 1550 15214610.93
NVS017 NERVE AND NERVE ROOT DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 377 3878405.64
NVS019 NERVOUS SYSTEM PAIN AND PAIN SYNDROMES -1 INAPPLICABLE -1 INAPPLICABLE 392 3691649.98
NVS020 OTHER SPECIFIED NERVOUS SYSTEM DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 45 423568.86
PNL000 CERTAIN CONDITIONS ORIGINATING IN THE PERINATAL PERIOD -1 INAPPLICABLE -1 INAPPLICABLE 9 145289.29
PNL001 LIVEBORN -1 INAPPLICABLE -1 INAPPLICABLE 53 870585.24
PRG000 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM -1 INAPPLICABLE -1 INAPPLICABLE 118 1380661.13
PRG000 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM SYM000 SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC -1 INAPPLICABLE 1 10441.44
PRG029 UNCOMPLICATED PREGNANCY, DELIVERY OR PUERPERIUM -1 INAPPLICABLE -1 INAPPLICABLE 330 4121354.13
RSP000 DISEASES OF THE RESPIRATORY SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 105 1187127.86
RSP001 SINUSITIS -1 INAPPLICABLE -1 INAPPLICABLE 518 6808221.11
RSP002 PNEUMONIA (EXCEPT THAT CAUSED BY TUBERCULOSIS) -1 INAPPLICABLE -1 INAPPLICABLE 279 2843204.02
RSP003 INFLUENZA -1 INAPPLICABLE -1 INAPPLICABLE 158 1691895.02
RSP004 ACUTE AND CHRONIC TONSILLITIS -1 INAPPLICABLE -1 INAPPLICABLE 44 567819.78
RSP005 ACUTE BRONCHITIS -1 INAPPLICABLE -1 INAPPLICABLE 219 2379075.79
RSP006 OTHER SPECIFIED UPPER RESPIRATORY INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE 509 6221716.66
RSP007 OTHER SPECIFIED AND UNSPECIFIED UPPER RESPIRATORY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 299 3143866.29
RSP008 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIECTASIS -1 INAPPLICABLE -1 INAPPLICABLE 698 5476151.50
RSP009 ASTHMA -1 INAPPLICABLE -1 INAPPLICABLE 1824 18827277.46
RSP016 OTHER SPECIFIED AND UNSPECIFIED LOWER RESPIRATORY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 207 2449636.59
SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE -1 INAPPLICABLE 136 1627975.45
SKN001 SKIN AND SUBCUTANEOUS TISSUE INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE 359 3915711.57
SKN002 OTHER SPECIFIED INFLAMMATORY CONDITION OF SKIN -1 INAPPLICABLE -1 INAPPLICABLE 616 7888153.68
SKN007 OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 1161 12795344.70
SYM000 SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC -1 INAPPLICABLE -1 INAPPLICABLE 136 1405483.11
SYM001 SYNCOPE -1 INAPPLICABLE -1 INAPPLICABLE 53 508076.92
SYM002 FEVER -1 INAPPLICABLE -1 INAPPLICABLE 126 1634257.43
SYM004 NAUSEA AND VOMITING -1 INAPPLICABLE -1 INAPPLICABLE 314 3349551.08
SYM006 ABDOMINAL PAIN & OTHER DIGESTIVE/ABDOMEN SIGNS AND SYMPTO -1 INAPPLICABLE -1 INAPPLICABLE 704 7141767.28
SYM007 MALAISE AND FATIGUE -1 INAPPLICABLE -1 INAPPLICABLE 147 1451001.92
SYM008 SYMPTOMS OF MENTAL AND SUBSTANCE USE CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE 44 422460.58
SYM010 NERVOUS SYSTEM SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE 431 4155891.42
SYM011 GENITOURINARY SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE 253 2539337.91
SYM012 CIRCULATORY SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE 474 4961124.91
SYM013 RESPIRATORY SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE 702 7329967.49
SYM014 SKIN/SUBCUTANEOUS SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE 512 5447717.08
SYM015 GENERAL SENSATION/PERCEPTION SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE 327 3038004.99
SYM016 OTHER GENERAL SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE 1247 10821548.68
SYM017 ABNORMAL FINDINGS WITHOUT DIAGNOSIS -1 INAPPLICABLE -1 INAPPLICABLE 591 6087613.72
94641 984161434.18

Return To Table Of Contents

Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364